id	sid	tid	token	lemma	pos
cord-301107-0njnjqeb	1	1	key	key	NN
cord-301107-0njnjqeb	1	2	:	:	:
cord-301107-0njnjqeb	2	1	cord-301107	cord-301107	NNP
cord-301107-0njnjqeb	2	2	-	-	HYPH
cord-301107-0njnjqeb	2	3	0njnjqeb	0njnjqeb	CD
cord-301107-0njnjqeb	2	4	authors	author	NNS
cord-301107-0njnjqeb	2	5	:	:	:
cord-301107-0njnjqeb	2	6	Dursun	Dursun	NNP
cord-301107-0njnjqeb	2	7	,	,	,
cord-301107-0njnjqeb	2	8	Recep	Recep	NNP
cord-301107-0njnjqeb	2	9	;	;	:
cord-301107-0njnjqeb	2	10	Temiz	Temiz	NNP
cord-301107-0njnjqeb	2	11	,	,	,
cord-301107-0njnjqeb	2	12	Selami	Selami	NNP
cord-301107-0njnjqeb	2	13	Aykut	Aykut	NNP
cord-301107-0njnjqeb	2	14	title	title	NN
cord-301107-0njnjqeb	2	15	:	:	:
cord-301107-0njnjqeb	2	16	The	the	DT
cord-301107-0njnjqeb	2	17	Clinics	Clinics	NNPS
cord-301107-0njnjqeb	2	18	of	of	IN
cord-301107-0njnjqeb	2	19	HHV‐6	HHV‐6	NNP
cord-301107-0njnjqeb	2	20	infection	infection	NN
cord-301107-0njnjqeb	2	21	in	in	IN
cord-301107-0njnjqeb	2	22	COVID‐19	COVID‐19	NNP
cord-301107-0njnjqeb	2	23	pandemic	pandemic	NN
cord-301107-0njnjqeb	2	24	:	:	:
cord-301107-0njnjqeb	2	25	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	2	26	rosea	rosea	NN
cord-301107-0njnjqeb	2	27	and	and	CC
cord-301107-0njnjqeb	2	28	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	2	29	disease	disease	NN
cord-301107-0njnjqeb	2	30	date	date	NN
cord-301107-0njnjqeb	2	31	:	:	:
cord-301107-0njnjqeb	2	32	2020	2020	CD
cord-301107-0njnjqeb	2	33	-	-	HYPH
cord-301107-0njnjqeb	2	34	05	05	CD
cord-301107-0njnjqeb	2	35	-	-	HYPH
cord-301107-0njnjqeb	2	36	31	31	CD
cord-301107-0njnjqeb	2	37	journal	journal	NN
cord-301107-0njnjqeb	2	38	:	:	:
cord-301107-0njnjqeb	3	1	Dermatol	Dermatol	NNP
cord-301107-0njnjqeb	4	1	Ther	ther	JJ
cord-301107-0njnjqeb	4	2	DOI	DOI	NNP
cord-301107-0njnjqeb	4	3	:	:	:
cord-301107-0njnjqeb	5	1	10.1111	10.1111	CD
cord-301107-0njnjqeb	5	2	/	/	SYM
cord-301107-0njnjqeb	5	3	dth.13730	dth.13730	VBP
cord-301107-0njnjqeb	5	4	sha	sha	NNP
cord-301107-0njnjqeb	5	5	:	:	:
cord-301107-0njnjqeb	6	1	fd82598ab5926dbce395a9f70ece26085a5e4761	fd82598ab5926dbce395a9f70ece26085a5e4761	CC
cord-301107-0njnjqeb	6	2	doc_id	doc_id	CD
cord-301107-0njnjqeb	6	3	:	:	:
cord-301107-0njnjqeb	7	1	301107	301107	CD
cord-301107-0njnjqeb	7	2	cord_uid	cord_uid	NNS
cord-301107-0njnjqeb	7	3	:	:	:
cord-301107-0njnjqeb	8	1	0njnjqeb	0njnjqeb	NFP
cord-301107-0njnjqeb	8	2	A	a	DT
cord-301107-0njnjqeb	8	3	new	new	JJ
cord-301107-0njnjqeb	8	4	type	type	NN
cord-301107-0njnjqeb	8	5	of	of	IN
cord-301107-0njnjqeb	8	6	coronavirus	coronavirus	NN
cord-301107-0njnjqeb	8	7	family	family	NN
cord-301107-0njnjqeb	8	8	(	(	-LRB-
cord-301107-0njnjqeb	8	9	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-301107-0njnjqeb	8	10	)	)	-RRB-
cord-301107-0njnjqeb	8	11	,	,	,
cord-301107-0njnjqeb	8	12	which	which	WDT
cord-301107-0njnjqeb	8	13	can	can	MD
cord-301107-0njnjqeb	8	14	be	be	VB
cord-301107-0njnjqeb	8	15	found	find	VBN
cord-301107-0njnjqeb	8	16	in	in	IN
cord-301107-0njnjqeb	8	17	humans	human	NNS
cord-301107-0njnjqeb	8	18	and	and	CC
cord-301107-0njnjqeb	8	19	animals	animal	NNS
cord-301107-0njnjqeb	8	20	,	,	,
cord-301107-0njnjqeb	8	21	with	with	IN
cord-301107-0njnjqeb	8	22	many	many	JJ
cord-301107-0njnjqeb	8	23	varieties	variety	NNS
cord-301107-0njnjqeb	8	24	and	and	CC
cord-301107-0njnjqeb	8	25	clinical	clinical	JJ
cord-301107-0njnjqeb	8	26	symptoms	symptom	NNS
cord-301107-0njnjqeb	8	27	,	,	,
cord-301107-0njnjqeb	8	28	was	be	VBD
cord-301107-0njnjqeb	8	29	first	first	RB
cord-301107-0njnjqeb	8	30	seen	see	VBN
cord-301107-0njnjqeb	8	31	in	in	IN
cord-301107-0njnjqeb	8	32	Wuhan	Wuhan	NNP
cord-301107-0njnjqeb	8	33	,	,	,
cord-301107-0njnjqeb	8	34	China	China	NNP
cord-301107-0njnjqeb	8	35	in	in	IN
cord-301107-0njnjqeb	8	36	late	late	JJ
cord-301107-0njnjqeb	8	37	2019	2019	CD
cord-301107-0njnjqeb	8	38	,	,	,
cord-301107-0njnjqeb	8	39	under	under	IN
cord-301107-0njnjqeb	8	40	the	the	DT
cord-301107-0njnjqeb	8	41	name	name	NN
cord-301107-0njnjqeb	8	42	novel	novel	NN
cord-301107-0njnjqeb	8	43	Coronavirus	Coronavirus	NNP
cord-301107-0njnjqeb	8	44	Disease	Disease	NNP
cord-301107-0njnjqeb	8	45	2019	2019	CD
cord-301107-0njnjqeb	9	1	(	(	-LRB-
cord-301107-0njnjqeb	9	2	COVID‐19	COVID‐19	NNP
cord-301107-0njnjqeb	9	3	)	)	-RRB-
cord-301107-0njnjqeb	9	4	.	.	.
cord-301107-0njnjqeb	10	1	In	in	IN
cord-301107-0njnjqeb	10	2	the	the	DT
cord-301107-0njnjqeb	10	3	literature	literature	NN
cord-301107-0njnjqeb	10	4	,	,	,
cord-301107-0njnjqeb	10	5	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	10	6	symptoms	symptom	NNS
cord-301107-0njnjqeb	10	7	related	relate	VBN
cord-301107-0njnjqeb	10	8	to	to	IN
cord-301107-0njnjqeb	10	9	the	the	DT
cord-301107-0njnjqeb	10	10	disease	disease	NN
cord-301107-0njnjqeb	10	11	are	be	VBP
cord-301107-0njnjqeb	10	12	generally	generally	RB
cord-301107-0njnjqeb	10	13	emphasized	emphasize	VBN
cord-301107-0njnjqeb	10	14	.	.	.
cord-301107-0njnjqeb	11	1	However	however	RB
cord-301107-0njnjqeb	11	2	,	,	,
cord-301107-0njnjqeb	11	3	it	-PRON-	PRP
cord-301107-0njnjqeb	11	4	is	be	VBZ
cord-301107-0njnjqeb	11	5	not	not	RB
cord-301107-0njnjqeb	11	6	yet	yet	RB
cord-301107-0njnjqeb	11	7	known	know	VBN
cord-301107-0njnjqeb	11	8	whether	whether	IN
cord-301107-0njnjqeb	11	9	this	this	DT
cord-301107-0njnjqeb	11	10	new	new	JJ
cord-301107-0njnjqeb	11	11	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-301107-0njnjqeb	11	12	virus	virus	NN
cord-301107-0njnjqeb	11	13	,	,	,
cord-301107-0njnjqeb	11	14	which	which	WDT
cord-301107-0njnjqeb	11	15	has	have	VBZ
cord-301107-0njnjqeb	11	16	entered	enter	VBN
cord-301107-0njnjqeb	11	17	our	-PRON-	PRP$
cord-301107-0njnjqeb	11	18	lives	life	NNS
cord-301107-0njnjqeb	11	19	,	,	,
cord-301107-0njnjqeb	11	20	plays	play	VBZ
cord-301107-0njnjqeb	11	21	a	a	DT
cord-301107-0njnjqeb	11	22	role	role	NN
cord-301107-0njnjqeb	11	23	in	in	IN
cord-301107-0njnjqeb	11	24	the	the	DT
cord-301107-0njnjqeb	11	25	etiopathogenesis	etiopathogenesis	NN
cord-301107-0njnjqeb	11	26	of	of	IN
cord-301107-0njnjqeb	11	27	dermatological	dermatological	JJ
cord-301107-0njnjqeb	11	28	diseases	disease	NNS
cord-301107-0njnjqeb	11	29	.	.	.
cord-301107-0njnjqeb	12	1	The	the	DT
cord-301107-0njnjqeb	12	2	patients	patient	NNS
cord-301107-0njnjqeb	12	3	who	who	WP
cord-301107-0njnjqeb	12	4	were	be	VBD
cord-301107-0njnjqeb	12	5	admitted	admit	VBN
cord-301107-0njnjqeb	12	6	to	to	IN
cord-301107-0njnjqeb	12	7	the	the	DT
cord-301107-0njnjqeb	12	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	12	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	12	10	clinic	clinic	NN
cord-301107-0njnjqeb	12	11	between	between	IN
cord-301107-0njnjqeb	12	12	1	1	CD
cord-301107-0njnjqeb	12	13	April	April	NNP
cord-301107-0njnjqeb	12	14	and	and	CC
cord-301107-0njnjqeb	12	15	May	May	NNP
cord-301107-0njnjqeb	12	16	15	15	CD
cord-301107-0njnjqeb	12	17	,	,	,
cord-301107-0njnjqeb	12	18	2019	2019	CD
cord-301107-0njnjqeb	12	19	,	,	,
cord-301107-0njnjqeb	12	20	and	and	CC
cord-301107-0njnjqeb	12	21	on	on	IN
cord-301107-0njnjqeb	12	22	1	1	CD
cord-301107-0njnjqeb	12	23	April	April	NNP
cord-301107-0njnjqeb	12	24	and	and	CC
cord-301107-0njnjqeb	12	25	May	May	NNP
cord-301107-0njnjqeb	12	26	15	15	CD
cord-301107-0njnjqeb	12	27	,	,	,
cord-301107-0njnjqeb	12	28	2020	2020	CD
cord-301107-0njnjqeb	12	29	were	be	VBD
cord-301107-0njnjqeb	12	30	retrospectively	retrospectively	RB
cord-301107-0njnjqeb	12	31	analyzed	analyze	VBN
cord-301107-0njnjqeb	12	32	by	by	IN
cord-301107-0njnjqeb	12	33	searching	search	VBG
cord-301107-0njnjqeb	12	34	the	the	DT
cord-301107-0njnjqeb	12	35	hospital	hospital	NN
cord-301107-0njnjqeb	12	36	automation	automation	NN
cord-301107-0njnjqeb	12	37	system	system	NN
cord-301107-0njnjqeb	12	38	and	and	CC
cord-301107-0njnjqeb	12	39	patient	patient	JJ
cord-301107-0njnjqeb	12	40	files	file	NNS
cord-301107-0njnjqeb	12	41	.	.	.
cord-301107-0njnjqeb	13	1	The	the	DT
cord-301107-0njnjqeb	13	2	reason	reason	NN
cord-301107-0njnjqeb	13	3	for	for	IN
cord-301107-0njnjqeb	13	4	the	the	DT
cord-301107-0njnjqeb	13	5	same	same	JJ
cord-301107-0njnjqeb	13	6	months	month	NNS
cord-301107-0njnjqeb	13	7	to	to	TO
cord-301107-0njnjqeb	13	8	be	be	VB
cord-301107-0njnjqeb	13	9	included	include	VBN
cord-301107-0njnjqeb	13	10	in	in	IN
cord-301107-0njnjqeb	13	11	the	the	DT
cord-301107-0njnjqeb	13	12	study	study	NN
cord-301107-0njnjqeb	13	13	was	be	VBD
cord-301107-0njnjqeb	13	14	to	to	TO
cord-301107-0njnjqeb	13	15	exclude	exclude	VB
cord-301107-0njnjqeb	13	16	seasonal	seasonal	JJ
cord-301107-0njnjqeb	13	17	effects	effect	NNS
cord-301107-0njnjqeb	13	18	on	on	IN
cord-301107-0njnjqeb	13	19	the	the	DT
cord-301107-0njnjqeb	13	20	diseases	disease	NNS
cord-301107-0njnjqeb	13	21	.	.	.
cord-301107-0njnjqeb	14	1	After	after	IN
cord-301107-0njnjqeb	14	2	pandemic	pandemic	NN
cord-301107-0njnjqeb	14	3	,	,	,
cord-301107-0njnjqeb	14	4	the	the	DT
cord-301107-0njnjqeb	14	5	number	number	NN
cord-301107-0njnjqeb	14	6	of	of	IN
cord-301107-0njnjqeb	14	7	patients	patient	NNS
cord-301107-0njnjqeb	14	8	with	with	IN
cord-301107-0njnjqeb	14	9	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	14	10	rosea	rosea	NN
cord-301107-0njnjqeb	14	11	and	and	CC
cord-301107-0njnjqeb	14	12	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	14	13	disease	disease	NN
cord-301107-0njnjqeb	14	14	increased	increase	VBD
cord-301107-0njnjqeb	14	15	significantly	significantly	RB
cord-301107-0njnjqeb	14	16	in	in	IN
cord-301107-0njnjqeb	14	17	patients	patient	NNS
cord-301107-0njnjqeb	14	18	who	who	WP
cord-301107-0njnjqeb	14	19	applied	apply	VBD
cord-301107-0njnjqeb	14	20	to	to	IN
cord-301107-0njnjqeb	14	21	the	the	DT
cord-301107-0njnjqeb	14	22	dermatology	dermatology	NN
cord-301107-0njnjqeb	14	23	outpatient	outpatient	NN
cord-301107-0njnjqeb	14	24	clinic	clinic	NN
cord-301107-0njnjqeb	14	25	.	.	.
cord-301107-0njnjqeb	15	1	Our	-PRON-	PRP$
cord-301107-0njnjqeb	15	2	study	study	NN
cord-301107-0njnjqeb	15	3	is	be	VBZ
cord-301107-0njnjqeb	15	4	the	the	DT
cord-301107-0njnjqeb	15	5	first	first	JJ
cord-301107-0njnjqeb	15	6	study	study	NN
cord-301107-0njnjqeb	15	7	showing	show	VBG
cord-301107-0njnjqeb	15	8	pityriasis	pityriasis	NN
cord-301107-0njnjqeb	15	9	rosea	rosea	NN
cord-301107-0njnjqeb	15	10	increase	increase	NN
cord-301107-0njnjqeb	15	11	during	during	IN
cord-301107-0njnjqeb	15	12	the	the	DT
cord-301107-0njnjqeb	15	13	pandemic	pandemic	NN
cord-301107-0njnjqeb	15	14	period	period	NN
cord-301107-0njnjqeb	15	15	.	.	.
cord-301107-0njnjqeb	16	1	We	-PRON-	PRP
cord-301107-0njnjqeb	16	2	think	think	VBP
cord-301107-0njnjqeb	16	3	that	that	IN
cord-301107-0njnjqeb	16	4	this	this	DT
cord-301107-0njnjqeb	16	5	increase	increase	NN
cord-301107-0njnjqeb	16	6	is	be	VBZ
cord-301107-0njnjqeb	16	7	related	relate	VBN
cord-301107-0njnjqeb	16	8	to	to	IN
cord-301107-0njnjqeb	16	9	HHV‐6	HHV‐6	NNP
cord-301107-0njnjqeb	16	10	reactivation	reactivation	NN
cord-301107-0njnjqeb	16	11	.	.	.
cord-301107-0njnjqeb	17	1	Herein	herein	RB
cord-301107-0njnjqeb	17	2	,	,	,
cord-301107-0njnjqeb	17	3	we	-PRON-	PRP
cord-301107-0njnjqeb	17	4	wanted	want	VBD
cord-301107-0njnjqeb	17	5	to	to	TO
cord-301107-0njnjqeb	17	6	draw	draw	VB
cord-301107-0njnjqeb	17	7	attention	attention	NN
cord-301107-0njnjqeb	17	8	to	to	IN
cord-301107-0njnjqeb	17	9	two	two	CD
cord-301107-0njnjqeb	17	10	diseases	disease	NNS
cord-301107-0njnjqeb	17	11	in	in	IN
cord-301107-0njnjqeb	17	12	which	which	WDT
cord-301107-0njnjqeb	17	13	Human	Human	NNP
cord-301107-0njnjqeb	17	14	Herpes	Herpes	NNP
cord-301107-0njnjqeb	17	15	6	6	CD
cord-301107-0njnjqeb	17	16	(	(	-LRB-
cord-301107-0njnjqeb	17	17	HHV‐6	HHV‐6	NNP
cord-301107-0njnjqeb	17	18	)	)	-RRB-
cord-301107-0njnjqeb	17	19	was	be	VBD
cord-301107-0njnjqeb	17	20	accused	accuse	VBN
cord-301107-0njnjqeb	17	21	in	in	IN
cord-301107-0njnjqeb	17	22	etiopathogenesis	etiopathogenesis	NN
cord-301107-0njnjqeb	17	23	:	:	:
cord-301107-0njnjqeb	17	24	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	17	25	disease	disease	NN
cord-301107-0njnjqeb	17	26	and	and	CC
cord-301107-0njnjqeb	17	27	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	17	28	rosea	rosea	NN
cord-301107-0njnjqeb	17	29	.	.	.
cord-301107-0njnjqeb	18	1	This	this	DT
cord-301107-0njnjqeb	18	2	article	article	NN
cord-301107-0njnjqeb	18	3	is	be	VBZ
cord-301107-0njnjqeb	18	4	protected	protect	VBN
cord-301107-0njnjqeb	18	5	by	by	IN
cord-301107-0njnjqeb	18	6	copyright	copyright	NN
cord-301107-0njnjqeb	18	7	.	.	.
cord-301107-0njnjqeb	19	1	All	all	DT
cord-301107-0njnjqeb	19	2	rights	right	NNS
cord-301107-0njnjqeb	19	3	reserved	reserve	VBN
cord-301107-0njnjqeb	19	4	.	.	.
cord-301107-0njnjqeb	20	1	A	a	DT
cord-301107-0njnjqeb	20	2	new	new	JJ
cord-301107-0njnjqeb	20	3	type	type	NN
cord-301107-0njnjqeb	20	4	of	of	IN
cord-301107-0njnjqeb	20	5	coronavirus	coronavirus	NN
cord-301107-0njnjqeb	20	6	family	family	NN
cord-301107-0njnjqeb	20	7	(	(	-LRB-
cord-301107-0njnjqeb	20	8	SARS	SARS	NNP
cord-301107-0njnjqeb	20	9	-	-	HYPH
cord-301107-0njnjqeb	20	10	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	20	11	)	)	-RRB-
cord-301107-0njnjqeb	20	12	,	,	,
cord-301107-0njnjqeb	20	13	which	which	WDT
cord-301107-0njnjqeb	20	14	can	can	MD
cord-301107-0njnjqeb	20	15	be	be	VB
cord-301107-0njnjqeb	20	16	found	find	VBN
cord-301107-0njnjqeb	20	17	in	in	IN
cord-301107-0njnjqeb	20	18	humans	human	NNS
cord-301107-0njnjqeb	20	19	and	and	CC
cord-301107-0njnjqeb	20	20	animals	animal	NNS
cord-301107-0njnjqeb	20	21	,	,	,
cord-301107-0njnjqeb	20	22	with	with	IN
cord-301107-0njnjqeb	20	23	many	many	JJ
cord-301107-0njnjqeb	20	24	varieties	variety	NNS
cord-301107-0njnjqeb	20	25	and	and	CC
cord-301107-0njnjqeb	20	26	clinical	clinical	JJ
cord-301107-0njnjqeb	20	27	symptoms	symptom	NNS
cord-301107-0njnjqeb	20	28	,	,	,
cord-301107-0njnjqeb	20	29	was	be	VBD
cord-301107-0njnjqeb	20	30	first	first	RB
cord-301107-0njnjqeb	20	31	seen	see	VBN
cord-301107-0njnjqeb	20	32	in	in	IN
cord-301107-0njnjqeb	20	33	Wuhan	Wuhan	NNP
cord-301107-0njnjqeb	20	34	,	,	,
cord-301107-0njnjqeb	20	35	China	China	NNP
cord-301107-0njnjqeb	20	36	in	in	IN
cord-301107-0njnjqeb	20	37	late	late	JJ
cord-301107-0njnjqeb	20	38	2019	2019	CD
cord-301107-0njnjqeb	20	39	,	,	,
cord-301107-0njnjqeb	20	40	under	under	IN
cord-301107-0njnjqeb	20	41	the	the	DT
cord-301107-0njnjqeb	20	42	name	name	NN
cord-301107-0njnjqeb	20	43	novel	novel	NN
cord-301107-0njnjqeb	20	44	Coronavirus	Coronavirus	NNP
cord-301107-0njnjqeb	20	45	Disease	Disease	NNP
cord-301107-0njnjqeb	20	46	2019	2019	CD
cord-301107-0njnjqeb	20	47	.	.	.
cord-301107-0njnjqeb	21	1	It	-PRON-	PRP
cord-301107-0njnjqeb	21	2	spread	spread	VBD
cord-301107-0njnjqeb	21	3	to	to	IN
cord-301107-0njnjqeb	21	4	the	the	DT
cord-301107-0njnjqeb	21	5	world	world	NN
cord-301107-0njnjqeb	21	6	very	very	RB
cord-301107-0njnjqeb	21	7	quickly	quickly	RB
cord-301107-0njnjqeb	21	8	,	,	,
cord-301107-0njnjqeb	21	9	and	and	CC
cord-301107-0njnjqeb	21	10	was	be	VBD
cord-301107-0njnjqeb	21	11	accepted	accept	VBN
cord-301107-0njnjqeb	21	12	as	as	IN
cord-301107-0njnjqeb	21	13	a	a	DT
cord-301107-0njnjqeb	21	14	pandemic	pandemic	NN
cord-301107-0njnjqeb	21	15	on	on	IN
cord-301107-0njnjqeb	21	16	March	March	NNP
cord-301107-0njnjqeb	21	17	11	11	CD
cord-301107-0njnjqeb	21	18	,	,	,
cord-301107-0njnjqeb	21	19	2020	2020	CD
cord-301107-0njnjqeb	21	20	(	(	-LRB-
cord-301107-0njnjqeb	21	21	1	1	CD
cord-301107-0njnjqeb	21	22	)	)	-RRB-
cord-301107-0njnjqeb	21	23	.	.	.
cord-301107-0njnjqeb	22	1	Clinical	clinical	JJ
cord-301107-0njnjqeb	22	2	,	,	,
cord-301107-0njnjqeb	22	3	therapeutic	therapeutic	JJ
cord-301107-0njnjqeb	22	4	,	,	,
cord-301107-0njnjqeb	22	5	vaccination	vaccination	NN
cord-301107-0njnjqeb	22	6	,	,	,
cord-301107-0njnjqeb	22	7	anti	anti	JJ
cord-301107-0njnjqeb	22	8	-	-	JJ
cord-301107-0njnjqeb	22	9	virus	virus	JJ
cord-301107-0njnjqeb	22	10	,	,	,
cord-301107-0njnjqeb	22	11	and	and	CC
cord-301107-0njnjqeb	22	12	anti	anti	JJ
cord-301107-0njnjqeb	22	13	-	-	JJ
cord-301107-0njnjqeb	22	14	spreading	spreading	JJ
cord-301107-0njnjqeb	22	15	studies	study	NNS
cord-301107-0njnjqeb	22	16	have	have	VBP
cord-301107-0njnjqeb	22	17	been	be	VBN
cord-301107-0njnjqeb	22	18	initiated	initiate	VBN
cord-301107-0njnjqeb	22	19	all	all	RB
cord-301107-0njnjqeb	22	20	over	over	IN
cord-301107-0njnjqeb	22	21	the	the	DT
cord-301107-0njnjqeb	22	22	world	world	NN
cord-301107-0njnjqeb	22	23	related	relate	VBN
cord-301107-0njnjqeb	22	24	to	to	IN
cord-301107-0njnjqeb	22	25	this	this	DT
cord-301107-0njnjqeb	22	26	virus	virus	NN
cord-301107-0njnjqeb	22	27	,	,	,
cord-301107-0njnjqeb	22	28	where	where	WRB
cord-301107-0njnjqeb	22	29	human	human	JJ
cord-301107-0njnjqeb	22	30	immunity	immunity	NN
cord-301107-0njnjqeb	22	31	was	be	VBD
cord-301107-0njnjqeb	22	32	first	first	RB
cord-301107-0njnjqeb	22	33	introduced	introduce	VBN
cord-301107-0njnjqeb	22	34	.	.	.
cord-301107-0njnjqeb	23	1	Because	because	IN
cord-301107-0njnjqeb	23	2	viral	viral	JJ
cord-301107-0njnjqeb	23	3	disease	disease	NN
cord-301107-0njnjqeb	23	4	was	be	VBD
cord-301107-0njnjqeb	23	5	spreading	spread	VBG
cord-301107-0njnjqeb	23	6	very	very	RB
cord-301107-0njnjqeb	23	7	fast	fast	RB
cord-301107-0njnjqeb	23	8	and	and	CC
cord-301107-0njnjqeb	23	9	had	have	VBD
cord-301107-0njnjqeb	23	10	a	a	DT
cord-301107-0njnjqeb	23	11	very	very	RB
cord-301107-0njnjqeb	23	12	lethal	lethal	JJ
cord-301107-0njnjqeb	23	13	feature	feature	NN
cord-301107-0njnjqeb	23	14	(	(	-LRB-
cord-301107-0njnjqeb	23	15	2	2	CD
cord-301107-0njnjqeb	23	16	)	)	-RRB-
cord-301107-0njnjqeb	23	17	.	.	.
cord-301107-0njnjqeb	24	1	It	-PRON-	PRP
cord-301107-0njnjqeb	24	2	is	be	VBZ
cord-301107-0njnjqeb	24	3	also	also	RB
cord-301107-0njnjqeb	24	4	reported	report	VBN
cord-301107-0njnjqeb	24	5	that	that	IN
cord-301107-0njnjqeb	24	6	there	there	EX
cord-301107-0njnjqeb	24	7	are	be	VBP
cord-301107-0njnjqeb	24	8	many	many	JJ
cord-301107-0njnjqeb	24	9	patients	patient	NNS
cord-301107-0njnjqeb	24	10	with	with	IN
cord-301107-0njnjqeb	24	11	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	24	12	disease	disease	NN
cord-301107-0njnjqeb	24	13	asymptomatic	asymptomatic	JJ
cord-301107-0njnjqeb	24	14	.	.	.
cord-301107-0njnjqeb	25	1	There	there	EX
cord-301107-0njnjqeb	25	2	are	be	VBP
cord-301107-0njnjqeb	25	3	many	many	JJ
cord-301107-0njnjqeb	25	4	publications	publication	NNS
cord-301107-0njnjqeb	25	5	about	about	IN
cord-301107-0njnjqeb	25	6	the	the	DT
cord-301107-0njnjqeb	25	7	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	25	8	findings	finding	NNS
cord-301107-0njnjqeb	25	9	of	of	IN
cord-301107-0njnjqeb	25	10	the	the	DT
cord-301107-0njnjqeb	25	11	disease	disease	NN
cord-301107-0njnjqeb	25	12	.	.	.
cord-301107-0njnjqeb	26	1	In	in	IN
cord-301107-0njnjqeb	26	2	the	the	DT
cord-301107-0njnjqeb	26	3	literature	literature	NN
cord-301107-0njnjqeb	26	4	,	,	,
cord-301107-0njnjqeb	26	5	disease	disease	NN
cord-301107-0njnjqeb	26	6	-	-	HYPH
cord-301107-0njnjqeb	26	7	related	relate	VBN
cord-301107-0njnjqeb	26	8	skin	skin	NN
cord-301107-0njnjqeb	26	9	lesions	lesion	NNS
cord-301107-0njnjqeb	26	10	have	have	VBP
cord-301107-0njnjqeb	26	11	been	be	VBN
cord-301107-0njnjqeb	26	12	reported	report	VBN
cord-301107-0njnjqeb	26	13	in	in	IN
cord-301107-0njnjqeb	26	14	approximately	approximately	RB
cord-301107-0njnjqeb	26	15	2	2	CD
cord-301107-0njnjqeb	26	16	-	-	SYM
cord-301107-0njnjqeb	26	17	20	20	CD
cord-301107-0njnjqeb	26	18	%	%	NN
cord-301107-0njnjqeb	26	19	of	of	IN
cord-301107-0njnjqeb	26	20	COVID-19	covid-19	JJ
cord-301107-0njnjqeb	26	21	patients	patient	NNS
cord-301107-0njnjqeb	26	22	(	(	-LRB-
cord-301107-0njnjqeb	26	23	3	3	CD
cord-301107-0njnjqeb	26	24	)	)	-RRB-
cord-301107-0njnjqeb	26	25	.	.	.
cord-301107-0njnjqeb	27	1	In	in	IN
cord-301107-0njnjqeb	27	2	the	the	DT
cord-301107-0njnjqeb	27	3	literature	literature	NN
cord-301107-0njnjqeb	27	4	,	,	,
cord-301107-0njnjqeb	27	5	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	27	6	symptoms	symptom	NNS
cord-301107-0njnjqeb	27	7	related	relate	VBN
cord-301107-0njnjqeb	27	8	to	to	IN
cord-301107-0njnjqeb	27	9	the	the	DT
cord-301107-0njnjqeb	27	10	disease	disease	NN
cord-301107-0njnjqeb	27	11	are	be	VBP
cord-301107-0njnjqeb	27	12	generally	generally	RB
cord-301107-0njnjqeb	27	13	emphasized	emphasize	VBN
cord-301107-0njnjqeb	27	14	.	.	.
cord-301107-0njnjqeb	28	1	However	however	RB
cord-301107-0njnjqeb	28	2	,	,	,
cord-301107-0njnjqeb	28	3	it	-PRON-	PRP
cord-301107-0njnjqeb	28	4	is	be	VBZ
cord-301107-0njnjqeb	28	5	not	not	RB
cord-301107-0njnjqeb	28	6	yet	yet	RB
cord-301107-0njnjqeb	28	7	known	know	VBN
cord-301107-0njnjqeb	28	8	whether	whether	IN
cord-301107-0njnjqeb	28	9	this	this	DT
cord-301107-0njnjqeb	28	10	new	new	JJ
cord-301107-0njnjqeb	28	11	SARS	SARS	NNP
cord-301107-0njnjqeb	28	12	-	-	HYPH
cord-301107-0njnjqeb	28	13	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	28	14	virus	virus	NN
cord-301107-0njnjqeb	28	15	,	,	,
cord-301107-0njnjqeb	28	16	which	which	WDT
cord-301107-0njnjqeb	28	17	has	have	VBZ
cord-301107-0njnjqeb	28	18	entered	enter	VBN
cord-301107-0njnjqeb	28	19	our	-PRON-	PRP$
cord-301107-0njnjqeb	28	20	lives	life	NNS
cord-301107-0njnjqeb	28	21	,	,	,
cord-301107-0njnjqeb	28	22	plays	play	VBZ
cord-301107-0njnjqeb	28	23	a	a	DT
cord-301107-0njnjqeb	28	24	role	role	NN
cord-301107-0njnjqeb	28	25	in	in	IN
cord-301107-0njnjqeb	28	26	the	the	DT
cord-301107-0njnjqeb	28	27	etiopathogenesis	etiopathogenesis	NN
cord-301107-0njnjqeb	28	28	of	of	IN
cord-301107-0njnjqeb	28	29	dermatological	dermatological	JJ
cord-301107-0njnjqeb	28	30	diseases	disease	NNS
cord-301107-0njnjqeb	28	31	(	(	-LRB-
cord-301107-0njnjqeb	28	32	4	4	CD
cord-301107-0njnjqeb	28	33	)	)	-RRB-
cord-301107-0njnjqeb	28	34	.	.	.
cord-301107-0njnjqeb	29	1	Herein	herein	RB
cord-301107-0njnjqeb	29	2	,	,	,
cord-301107-0njnjqeb	29	3	we	-PRON-	PRP
cord-301107-0njnjqeb	29	4	wanted	want	VBD
cord-301107-0njnjqeb	29	5	to	to	TO
cord-301107-0njnjqeb	29	6	aim	aim	VB
cord-301107-0njnjqeb	29	7	to	to	TO
cord-301107-0njnjqeb	29	8	evaluate	evaluate	VB
cord-301107-0njnjqeb	29	9	whether	whether	IN
cord-301107-0njnjqeb	29	10	two	two	CD
cord-301107-0njnjqeb	29	11	diseases	disease	NNS
cord-301107-0njnjqeb	29	12	(	(	-LRB-
cord-301107-0njnjqeb	29	13	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	29	14	rosea	rosea	NN
cord-301107-0njnjqeb	29	15	and	and	CC
cord-301107-0njnjqeb	29	16	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	29	17	disease	disease	NN
cord-301107-0njnjqeb	29	18	)	)	-RRB-
cord-301107-0njnjqeb	29	19	,	,	,
cord-301107-0njnjqeb	29	20	in	in	IN
cord-301107-0njnjqeb	29	21	which	which	WDT
cord-301107-0njnjqeb	29	22	Human	Human	NNP
cord-301107-0njnjqeb	29	23	Herpesvirus	Herpesvirus	NNP
cord-301107-0njnjqeb	29	24	6	6	CD
cord-301107-0njnjqeb	29	25	(	(	-LRB-
cord-301107-0njnjqeb	29	26	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	29	27	)	)	-RRB-
cord-301107-0njnjqeb	29	28	was	be	VBD
cord-301107-0njnjqeb	29	29	held	hold	VBN
cord-301107-0njnjqeb	29	30	responsible	responsible	JJ
cord-301107-0njnjqeb	29	31	for	for	IN
cord-301107-0njnjqeb	29	32	etiopathogenesis	etiopathogenesis	NNP
cord-301107-0njnjqeb	29	33	,	,	,
cord-301107-0njnjqeb	29	34	after	after	IN
cord-301107-0njnjqeb	29	35	the	the	DT
cord-301107-0njnjqeb	29	36	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	29	37	pandemic	pandemic	NN
cord-301107-0njnjqeb	29	38	.	.	.
cord-301107-0njnjqeb	30	1	This	this	DT
cord-301107-0njnjqeb	30	2	study	study	NN
cord-301107-0njnjqeb	30	3	was	be	VBD
cord-301107-0njnjqeb	30	4	conducted	conduct	VBN
cord-301107-0njnjqeb	30	5	at	at	IN
cord-301107-0njnjqeb	30	6	the	the	DT
cord-301107-0njnjqeb	30	7	Necmettin	Necmettin	NNP
cord-301107-0njnjqeb	30	8	Erbakan	Erbakan	NNP
cord-301107-0njnjqeb	30	9	University	University	NNP
cord-301107-0njnjqeb	30	10	Hospital	Hospital	NNP
cord-301107-0njnjqeb	30	11	,	,	,
cord-301107-0njnjqeb	30	12	a	a	DT
cord-301107-0njnjqeb	30	13	major	major	JJ
cord-301107-0njnjqeb	30	14	tertiary	tertiary	JJ
cord-301107-0njnjqeb	30	15	hospital	hospital	NN
cord-301107-0njnjqeb	30	16	,	,	,
cord-301107-0njnjqeb	30	17	and	and	CC
cord-301107-0njnjqeb	30	18	sees	see	VBZ
cord-301107-0njnjqeb	30	19	over	over	IN
cord-301107-0njnjqeb	30	20	1,200,000	1,200,000	CD
cord-301107-0njnjqeb	30	21	patients	patient	NNS
cord-301107-0njnjqeb	30	22	per	per	IN
cord-301107-0njnjqeb	30	23	year	year	NN
cord-301107-0njnjqeb	30	24	.	.	.
cord-301107-0njnjqeb	31	1	The	the	DT
cord-301107-0njnjqeb	31	2	patients	patient	NNS
cord-301107-0njnjqeb	31	3	who	who	WP
cord-301107-0njnjqeb	31	4	were	be	VBD
cord-301107-0njnjqeb	31	5	admitted	admit	VBN
cord-301107-0njnjqeb	31	6	to	to	IN
cord-301107-0njnjqeb	31	7	the	the	DT
cord-301107-0njnjqeb	31	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	31	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	31	10	clinic	clinic	NN
cord-301107-0njnjqeb	31	11	between	between	IN
cord-301107-0njnjqeb	31	12	1	1	CD
cord-301107-0njnjqeb	31	13	April	April	NNP
cord-301107-0njnjqeb	31	14	and	and	CC
cord-301107-0njnjqeb	31	15	15	15	CD
cord-301107-0njnjqeb	31	16	May	May	NNP
cord-301107-0njnjqeb	31	17	2019	2019	CD
cord-301107-0njnjqeb	31	18	,	,	,
cord-301107-0njnjqeb	31	19	and	and	CC
cord-301107-0njnjqeb	31	20	on	on	IN
cord-301107-0njnjqeb	31	21	1	1	CD
cord-301107-0njnjqeb	31	22	April	April	NNP
cord-301107-0njnjqeb	31	23	and	and	CC
cord-301107-0njnjqeb	31	24	15	15	CD
cord-301107-0njnjqeb	31	25	May	May	NNP
cord-301107-0njnjqeb	31	26	2020	2020	CD
cord-301107-0njnjqeb	31	27	were	be	VBD
cord-301107-0njnjqeb	31	28	retrospectively	retrospectively	RB
cord-301107-0njnjqeb	31	29	analyzed	analyze	VBN
cord-301107-0njnjqeb	31	30	by	by	IN
cord-301107-0njnjqeb	31	31	searching	search	VBG
cord-301107-0njnjqeb	31	32	the	the	DT
cord-301107-0njnjqeb	31	33	hospital	hospital	NN
cord-301107-0njnjqeb	31	34	automation	automation	NN
cord-301107-0njnjqeb	31	35	system	system	NN
cord-301107-0njnjqeb	31	36	and	and	CC
cord-301107-0njnjqeb	31	37	patient	patient	JJ
cord-301107-0njnjqeb	31	38	files	file	NNS
cord-301107-0njnjqeb	31	39	.	.	.
cord-301107-0njnjqeb	32	1	The	the	DT
cord-301107-0njnjqeb	32	2	reason	reason	NN
cord-301107-0njnjqeb	32	3	for	for	IN
cord-301107-0njnjqeb	32	4	the	the	DT
cord-301107-0njnjqeb	32	5	same	same	JJ
cord-301107-0njnjqeb	32	6	months	month	NNS
cord-301107-0njnjqeb	32	7	to	to	TO
cord-301107-0njnjqeb	32	8	be	be	VB
cord-301107-0njnjqeb	32	9	included	include	VBN
cord-301107-0njnjqeb	32	10	in	in	IN
cord-301107-0njnjqeb	32	11	the	the	DT
cord-301107-0njnjqeb	32	12	study	study	NN
cord-301107-0njnjqeb	32	13	was	be	VBD
cord-301107-0njnjqeb	32	14	to	to	TO
cord-301107-0njnjqeb	32	15	exclude	exclude	VB
cord-301107-0njnjqeb	32	16	seasonal	seasonal	JJ
cord-301107-0njnjqeb	32	17	effects	effect	NNS
cord-301107-0njnjqeb	32	18	on	on	IN
cord-301107-0njnjqeb	32	19	the	the	DT
cord-301107-0njnjqeb	32	20	diseases	disease	NNS
cord-301107-0njnjqeb	32	21	.	.	.
cord-301107-0njnjqeb	33	1	In	in	IN
cord-301107-0njnjqeb	33	2	the	the	DT
cord-301107-0njnjqeb	33	3	evaluation	evaluation	NN
cord-301107-0njnjqeb	33	4	made	make	VBN
cord-301107-0njnjqeb	33	5	based	base	VBN
cord-301107-0njnjqeb	33	6	on	on	IN
cord-301107-0njnjqeb	33	7	before	before	RB
cord-301107-0njnjqeb	33	8	and	and	CC
cord-301107-0njnjqeb	33	9	after	after	IN
cord-301107-0njnjqeb	33	10	the	the	DT
cord-301107-0njnjqeb	33	11	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	33	12	pandemic	pandemic	NN
cord-301107-0njnjqeb	33	13	,	,	,
cord-301107-0njnjqeb	33	14	the	the	DT
cord-301107-0njnjqeb	33	15	total	total	JJ
cord-301107-0njnjqeb	33	16	number	number	NN
cord-301107-0njnjqeb	33	17	of	of	IN
cord-301107-0njnjqeb	33	18	patients	patient	NNS
cord-301107-0njnjqeb	33	19	admitted	admit	VBN
cord-301107-0njnjqeb	33	20	to	to	IN
cord-301107-0njnjqeb	33	21	the	the	DT
cord-301107-0njnjqeb	33	22	outpatient	outpatient	NN
cord-301107-0njnjqeb	33	23	clinic	clinic	NN
cord-301107-0njnjqeb	33	24	during	during	IN
cord-301107-0njnjqeb	33	25	these	these	DT
cord-301107-0njnjqeb	33	26	periods	period	NNS
cord-301107-0njnjqeb	33	27	was	be	VBD
cord-301107-0njnjqeb	33	28	determined	determine	VBN
cord-301107-0njnjqeb	33	29	.	.	.
cord-301107-0njnjqeb	34	1	The	the	DT
cord-301107-0njnjqeb	34	2	numbers	number	NNS
cord-301107-0njnjqeb	34	3	and	and	CC
cord-301107-0njnjqeb	34	4	rates	rate	NNS
cord-301107-0njnjqeb	34	5	of	of	IN
cord-301107-0njnjqeb	34	6	patients	patient	NNS
cord-301107-0njnjqeb	34	7	with	with	IN
cord-301107-0njnjqeb	34	8	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	34	9	rosea	rosea	NN
cord-301107-0njnjqeb	34	10	and	and	CC
cord-301107-0njnjqeb	34	11	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	34	12	disease	disease	NN
cord-301107-0njnjqeb	34	13	among	among	IN
cord-301107-0njnjqeb	34	14	the	the	DT
cord-301107-0njnjqeb	34	15	total	total	JJ
cord-301107-0njnjqeb	34	16	patients	patient	NNS
cord-301107-0njnjqeb	34	17	who	who	WP
cord-301107-0njnjqeb	34	18	applied	apply	VBD
cord-301107-0njnjqeb	34	19	to	to	IN
cord-301107-0njnjqeb	34	20	the	the	DT
cord-301107-0njnjqeb	34	21	outpatient	outpatient	NN
cord-301107-0njnjqeb	34	22	clinic	clinic	NN
cord-301107-0njnjqeb	34	23	were	be	VBD
cord-301107-0njnjqeb	34	24	calculated	calculate	VBN
cord-301107-0njnjqeb	34	25	.	.	.
cord-301107-0njnjqeb	35	1	Local	local	JJ
cord-301107-0njnjqeb	35	2	ethics	ethic	NNS
cord-301107-0njnjqeb	35	3	committee	committee	NN
cord-301107-0njnjqeb	35	4	approval	approval	NN
cord-301107-0njnjqeb	35	5	was	be	VBD
cord-301107-0njnjqeb	35	6	also	also	RB
cord-301107-0njnjqeb	35	7	obtained	obtain	VBN
cord-301107-0njnjqeb	35	8	for	for	IN
cord-301107-0njnjqeb	35	9	the	the	DT
cord-301107-0njnjqeb	35	10	study	study	NN
cord-301107-0njnjqeb	35	11	.	.	.
cord-301107-0njnjqeb	36	1	Data	data	NN
cord-301107-0njnjqeb	36	2	analysis	analysis	NN
cord-301107-0njnjqeb	36	3	was	be	VBD
cord-301107-0njnjqeb	36	4	performed	perform	VBN
cord-301107-0njnjqeb	36	5	using	use	VBG
cord-301107-0njnjqeb	36	6	the	the	DT
cord-301107-0njnjqeb	36	7	SPSS	SPSS	NNP
cord-301107-0njnjqeb	36	8	22.0	22.0	CD
cord-301107-0njnjqeb	36	9	program	program	NN
cord-301107-0njnjqeb	36	10	.	.	.
cord-301107-0njnjqeb	37	1	Mean	mean	JJ
cord-301107-0njnjqeb	37	2	±	±	NNP
cord-301107-0njnjqeb	37	3	standard	standard	JJ
cord-301107-0njnjqeb	37	4	deviation	deviation	NN
cord-301107-0njnjqeb	37	5	and	and	CC
cord-301107-0njnjqeb	37	6	percentage	percentage	NN
cord-301107-0njnjqeb	37	7	were	be	VBD
cord-301107-0njnjqeb	37	8	used	use	VBN
cord-301107-0njnjqeb	37	9	for	for	IN
cord-301107-0njnjqeb	37	10	descriptive	descriptive	JJ
cord-301107-0njnjqeb	37	11	statistics	statistic	NNS
cord-301107-0njnjqeb	37	12	.	.	.
cord-301107-0njnjqeb	38	1	Chi	Chi	NNP
cord-301107-0njnjqeb	38	2	-	-	HYPH
cord-301107-0njnjqeb	38	3	square	square	JJ
cord-301107-0njnjqeb	38	4	test	test	NN
cord-301107-0njnjqeb	38	5	was	be	VBD
cord-301107-0njnjqeb	38	6	performed	perform	VBN
cord-301107-0njnjqeb	38	7	and	and	CC
cord-301107-0njnjqeb	38	8	the	the	DT
cord-301107-0njnjqeb	38	9	p	p	NN
cord-301107-0njnjqeb	38	10	value	value	NN
cord-301107-0njnjqeb	38	11	of	of	IN
cord-301107-0njnjqeb	38	12	less	less	JJR
cord-301107-0njnjqeb	38	13	than	than	IN
cord-301107-0njnjqeb	38	14	0.05	0.05	CD
cord-301107-0njnjqeb	38	15	was	be	VBD
cord-301107-0njnjqeb	38	16	accepted	accept	VBN
cord-301107-0njnjqeb	38	17	as	as	IN
cord-301107-0njnjqeb	38	18	statistically	statistically	RB
cord-301107-0njnjqeb	38	19	significant	significant	JJ
cord-301107-0njnjqeb	38	20	.	.	.
cord-301107-0njnjqeb	39	1	The	the	DT
cord-301107-0njnjqeb	39	2	total	total	JJ
cord-301107-0njnjqeb	39	3	number	number	NN
cord-301107-0njnjqeb	39	4	of	of	IN
cord-301107-0njnjqeb	39	5	patients	patient	NNS
cord-301107-0njnjqeb	39	6	admitted	admit	VBN
cord-301107-0njnjqeb	39	7	to	to	IN
cord-301107-0njnjqeb	39	8	the	the	DT
cord-301107-0njnjqeb	39	9	dermatology	dermatology	NN
cord-301107-0njnjqeb	39	10	outpatient	outpatient	NN
cord-301107-0njnjqeb	39	11	clinic	clinic	NN
cord-301107-0njnjqeb	39	12	between	between	IN
cord-301107-0njnjqeb	39	13	1	1	CD
cord-301107-0njnjqeb	39	14	April	April	NNP
cord-301107-0njnjqeb	39	15	and	and	CC
cord-301107-0njnjqeb	39	16	15	15	CD
cord-301107-0njnjqeb	40	1	May	May	NNP
cord-301107-0njnjqeb	40	2	2019	2019	CD
cord-301107-0njnjqeb	40	3	was	be	VBD
cord-301107-0njnjqeb	40	4	6467	6467	CD
cord-301107-0njnjqeb	40	5	.	.	.
cord-301107-0njnjqeb	41	1	Female	female	JJ
cord-301107-0njnjqeb	41	2	patients	patient	NNS
cord-301107-0njnjqeb	41	3	had	have	VBD
cord-301107-0njnjqeb	41	4	a	a	DT
cord-301107-0njnjqeb	41	5	slight	slight	JJ
cord-301107-0njnjqeb	41	6	predominance	predominance	NN
cord-301107-0njnjqeb	41	7	(	(	-LRB-
cord-301107-0njnjqeb	41	8	55.9	55.9	CD
cord-301107-0njnjqeb	41	9	%	%	NN
cord-301107-0njnjqeb	41	10	)	)	-RRB-
cord-301107-0njnjqeb	41	11	.	.	.
cord-301107-0njnjqeb	42	1	The	the	DT
cord-301107-0njnjqeb	42	2	mean	mean	JJ
cord-301107-0njnjqeb	42	3	age	age	NN
cord-301107-0njnjqeb	42	4	of	of	IN
cord-301107-0njnjqeb	42	5	patients	patient	NNS
cord-301107-0njnjqeb	42	6	was	be	VBD
cord-301107-0njnjqeb	42	7	35.7	35.7	CD
cord-301107-0njnjqeb	42	8	±	±	CD
cord-301107-0njnjqeb	42	9	29.1	29.1	CD
cord-301107-0njnjqeb	42	10	.	.	.
cord-301107-0njnjqeb	43	1	The	the	DT
cord-301107-0njnjqeb	43	2	total	total	JJ
cord-301107-0njnjqeb	43	3	number	number	NN
cord-301107-0njnjqeb	43	4	of	of	IN
cord-301107-0njnjqeb	43	5	patients	patient	NNS
cord-301107-0njnjqeb	43	6	admitted	admit	VBN
cord-301107-0njnjqeb	43	7	to	to	IN
cord-301107-0njnjqeb	43	8	the	the	DT
cord-301107-0njnjqeb	43	9	dermatology	dermatology	NN
cord-301107-0njnjqeb	43	10	outpatient	outpatient	NN
cord-301107-0njnjqeb	43	11	clinic	clinic	NN
cord-301107-0njnjqeb	43	12	between	between	IN
cord-301107-0njnjqeb	43	13	1	1	CD
cord-301107-0njnjqeb	43	14	April	April	NNP
cord-301107-0njnjqeb	43	15	and	and	CC
cord-301107-0njnjqeb	43	16	15	15	CD
cord-301107-0njnjqeb	43	17	May	May	NNP
cord-301107-0njnjqeb	43	18	2020	2020	CD
cord-301107-0njnjqeb	43	19	was	be	VBD
cord-301107-0njnjqeb	43	20	1292	1292	CD
cord-301107-0njnjqeb	43	21	.	.	.
cord-301107-0njnjqeb	44	1	Female	female	JJ
cord-301107-0njnjqeb	44	2	patients	patient	NNS
cord-301107-0njnjqeb	44	3	had	have	VBD
cord-301107-0njnjqeb	44	4	a	a	DT
cord-301107-0njnjqeb	44	5	slight	slight	JJ
cord-301107-0njnjqeb	44	6	predominance	predominance	NN
cord-301107-0njnjqeb	44	7	(	(	-LRB-
cord-301107-0njnjqeb	44	8	54.8	54.8	CD
cord-301107-0njnjqeb	44	9	%	%	NN
cord-301107-0njnjqeb	44	10	)	)	-RRB-
cord-301107-0njnjqeb	44	11	.	.	.
cord-301107-0njnjqeb	45	1	The	the	DT
cord-301107-0njnjqeb	45	2	mean	mean	JJ
cord-301107-0njnjqeb	45	3	age	age	NN
cord-301107-0njnjqeb	45	4	of	of	IN
cord-301107-0njnjqeb	45	5	patients	patient	NNS
cord-301107-0njnjqeb	45	6	was	be	VBD
cord-301107-0njnjqeb	45	7	36.6	36.6	CD
cord-301107-0njnjqeb	45	8	±	±	NNP
cord-301107-0njnjqeb	45	9	30.2	30.2	CD
cord-301107-0njnjqeb	45	10	.	.	.
cord-301107-0njnjqeb	46	1	In	in	IN
cord-301107-0njnjqeb	46	2	terms	term	NNS
cord-301107-0njnjqeb	46	3	of	of	IN
cord-301107-0njnjqeb	46	4	age	age	NN
cord-301107-0njnjqeb	46	5	and	and	CC
cord-301107-0njnjqeb	46	6	gender	gender	NN
cord-301107-0njnjqeb	46	7	,	,	,
cord-301107-0njnjqeb	46	8	there	there	EX
cord-301107-0njnjqeb	46	9	was	be	VBD
cord-301107-0njnjqeb	46	10	no	no	DT
cord-301107-0njnjqeb	46	11	significant	significant	JJ
cord-301107-0njnjqeb	46	12	difference	difference	NN
cord-301107-0njnjqeb	46	13	in	in	IN
cord-301107-0njnjqeb	46	14	outpatient	outpatient	NN
cord-301107-0njnjqeb	46	15	applications	application	NNS
cord-301107-0njnjqeb	46	16	before	before	IN
cord-301107-0njnjqeb	46	17	and	and	CC
cord-301107-0njnjqeb	46	18	after	after	IN
cord-301107-0njnjqeb	46	19	the	the	DT
cord-301107-0njnjqeb	46	20	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	46	21	pandemic	pandemic	NN
cord-301107-0njnjqeb	46	22	.	.	.
cord-301107-0njnjqeb	47	1	Table	table	NN
cord-301107-0njnjqeb	47	2	1	1	CD
cord-301107-0njnjqeb	47	3	shows	show	VBZ
cord-301107-0njnjqeb	47	4	the	the	DT
cord-301107-0njnjqeb	47	5	distribution	distribution	NN
cord-301107-0njnjqeb	47	6	of	of	IN
cord-301107-0njnjqeb	47	7	the	the	DT
cord-301107-0njnjqeb	47	8	patients	patient	NNS
cord-301107-0njnjqeb	47	9	who	who	WP
cord-301107-0njnjqeb	47	10	applied	apply	VBD
cord-301107-0njnjqeb	47	11	to	to	IN
cord-301107-0njnjqeb	47	12	the	the	DT
cord-301107-0njnjqeb	47	13	dermatology	dermatology	NN
cord-301107-0njnjqeb	47	14	outpatient	outpatient	NN
cord-301107-0njnjqeb	47	15	clinic	clinic	NN
cord-301107-0njnjqeb	47	16	before	before	IN
cord-301107-0njnjqeb	47	17	and	and	CC
cord-301107-0njnjqeb	47	18	after	after	IN
cord-301107-0njnjqeb	47	19	the	the	DT
cord-301107-0njnjqeb	47	20	pandemic	pandemic	NN
cord-301107-0njnjqeb	47	21	.	.	.
cord-301107-0njnjqeb	48	1	Among	among	IN
cord-301107-0njnjqeb	48	2	the	the	DT
cord-301107-0njnjqeb	48	3	patients	patient	NNS
cord-301107-0njnjqeb	48	4	who	who	WP
cord-301107-0njnjqeb	48	5	applied	apply	VBD
cord-301107-0njnjqeb	48	6	to	to	IN
cord-301107-0njnjqeb	48	7	the	the	DT
cord-301107-0njnjqeb	48	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	48	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	48	10	clinic	clinic	NN
cord-301107-0njnjqeb	48	11	between	between	IN
cord-301107-0njnjqeb	48	12	April	April	NNP
cord-301107-0njnjqeb	48	13	1	1	CD
cord-301107-0njnjqeb	48	14	and	and	CC
cord-301107-0njnjqeb	48	15	May	May	NNP
cord-301107-0njnjqeb	48	16	15	15	CD
cord-301107-0njnjqeb	48	17	,	,	,
cord-301107-0njnjqeb	48	18	2019	2019	CD
cord-301107-0njnjqeb	48	19	,	,	,
cord-301107-0njnjqeb	48	20	52	52	CD
cord-301107-0njnjqeb	48	21	patients	patient	NNS
cord-301107-0njnjqeb	48	22	(	(	-LRB-
cord-301107-0njnjqeb	48	23	0.8	0.8	CD
cord-301107-0njnjqeb	48	24	%	%	NN
cord-301107-0njnjqeb	48	25	)	)	-RRB-
cord-301107-0njnjqeb	48	26	were	be	VBD
cord-301107-0njnjqeb	48	27	diagnosed	diagnose	VBN
cord-301107-0njnjqeb	48	28	with	with	IN
cord-301107-0njnjqeb	48	29	Pityriasis	Pityriasis	NNP
cord-301107-0njnjqeb	48	30	rosae	rosae	NN
cord-301107-0njnjqeb	48	31	.	.	.
cord-301107-0njnjqeb	49	1	Among	among	IN
cord-301107-0njnjqeb	49	2	the	the	DT
cord-301107-0njnjqeb	49	3	patients	patient	NNS
cord-301107-0njnjqeb	49	4	who	who	WP
cord-301107-0njnjqeb	49	5	applied	apply	VBD
cord-301107-0njnjqeb	49	6	to	to	IN
cord-301107-0njnjqeb	49	7	the	the	DT
cord-301107-0njnjqeb	49	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	49	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	49	10	clinic	clinic	NN
cord-301107-0njnjqeb	49	11	between	between	IN
cord-301107-0njnjqeb	49	12	April	April	NNP
cord-301107-0njnjqeb	49	13	1	1	CD
cord-301107-0njnjqeb	49	14	and	and	CC
cord-301107-0njnjqeb	49	15	May	May	NNP
cord-301107-0njnjqeb	49	16	15	15	CD
cord-301107-0njnjqeb	49	17	,	,	,
cord-301107-0njnjqeb	49	18	2020	2020	CD
cord-301107-0njnjqeb	49	19	,	,	,
cord-301107-0njnjqeb	49	20	50	50	CD
cord-301107-0njnjqeb	49	21	patients	patient	NNS
cord-301107-0njnjqeb	49	22	(	(	-LRB-
cord-301107-0njnjqeb	49	23	3.9	3.9	CD
cord-301107-0njnjqeb	49	24	%	%	NN
cord-301107-0njnjqeb	49	25	)	)	-RRB-
cord-301107-0njnjqeb	49	26	were	be	VBD
cord-301107-0njnjqeb	49	27	diagnosed	diagnose	VBN
cord-301107-0njnjqeb	49	28	with	with	IN
cord-301107-0njnjqeb	49	29	Pityriasis	Pityriasis	NNP
cord-301107-0njnjqeb	49	30	rosae	rosae	NN
cord-301107-0njnjqeb	49	31	.	.	.
cord-301107-0njnjqeb	50	1	After	after	IN
cord-301107-0njnjqeb	50	2	pandemic	pandemic	NN
cord-301107-0njnjqeb	50	3	,	,	,
cord-301107-0njnjqeb	50	4	the	the	DT
cord-301107-0njnjqeb	50	5	number	number	NN
cord-301107-0njnjqeb	50	6	of	of	IN
cord-301107-0njnjqeb	50	7	patients	patient	NNS
cord-301107-0njnjqeb	50	8	with	with	IN
cord-301107-0njnjqeb	50	9	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	50	10	rosea	rosea	NN
cord-301107-0njnjqeb	50	11	increased	increase	VBD
cord-301107-0njnjqeb	50	12	significantly	significantly	RB
cord-301107-0njnjqeb	50	13	in	in	IN
cord-301107-0njnjqeb	50	14	patients	patient	NNS
cord-301107-0njnjqeb	50	15	who	who	WP
cord-301107-0njnjqeb	50	16	applied	apply	VBD
cord-301107-0njnjqeb	50	17	to	to	IN
cord-301107-0njnjqeb	50	18	the	the	DT
cord-301107-0njnjqeb	50	19	dermatology	dermatology	NN
cord-301107-0njnjqeb	50	20	outpatient	outpatient	NN
cord-301107-0njnjqeb	50	21	clinic	clinic	NN
cord-301107-0njnjqeb	50	22	(	(	-LRB-
cord-301107-0njnjqeb	50	23	p:0,000	p:0,000	NNP
cord-301107-0njnjqeb	50	24	)	)	-RRB-
cord-301107-0njnjqeb	50	25	.	.	.
cord-301107-0njnjqeb	51	1	Among	among	IN
cord-301107-0njnjqeb	51	2	the	the	DT
cord-301107-0njnjqeb	51	3	patients	patient	NNS
cord-301107-0njnjqeb	51	4	who	who	WP
cord-301107-0njnjqeb	51	5	applied	apply	VBD
cord-301107-0njnjqeb	51	6	to	to	IN
cord-301107-0njnjqeb	51	7	the	the	DT
cord-301107-0njnjqeb	51	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	51	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	51	10	clinic	clinic	NN
cord-301107-0njnjqeb	51	11	between	between	IN
cord-301107-0njnjqeb	51	12	April	April	NNP
cord-301107-0njnjqeb	51	13	1	1	CD
cord-301107-0njnjqeb	51	14	and	and	CC
cord-301107-0njnjqeb	51	15	May	May	NNP
cord-301107-0njnjqeb	51	16	15	15	CD
cord-301107-0njnjqeb	51	17	,	,	,
cord-301107-0njnjqeb	51	18	2019	2019	CD
cord-301107-0njnjqeb	51	19	,	,	,
cord-301107-0njnjqeb	51	20	2	2	CD
cord-301107-0njnjqeb	51	21	patients	patient	NNS
cord-301107-0njnjqeb	51	22	(	(	-LRB-
cord-301107-0njnjqeb	51	23	0.03	0.03	CD
cord-301107-0njnjqeb	51	24	%	%	NN
cord-301107-0njnjqeb	51	25	)	)	-RRB-
cord-301107-0njnjqeb	51	26	were	be	VBD
cord-301107-0njnjqeb	51	27	diagnosed	diagnose	VBN
cord-301107-0njnjqeb	51	28	with	with	IN
cord-301107-0njnjqeb	51	29	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	51	30	disease	disease	NN
cord-301107-0njnjqeb	51	31	.	.	.
cord-301107-0njnjqeb	52	1	Among	among	IN
cord-301107-0njnjqeb	52	2	the	the	DT
cord-301107-0njnjqeb	52	3	patients	patient	NNS
cord-301107-0njnjqeb	52	4	who	who	WP
cord-301107-0njnjqeb	52	5	applied	apply	VBD
cord-301107-0njnjqeb	52	6	to	to	IN
cord-301107-0njnjqeb	52	7	the	the	DT
cord-301107-0njnjqeb	52	8	dermatology	dermatology	NN
cord-301107-0njnjqeb	52	9	outpatient	outpatient	NN
cord-301107-0njnjqeb	52	10	clinic	clinic	NN
cord-301107-0njnjqeb	52	11	between	between	IN
cord-301107-0njnjqeb	52	12	April	April	NNP
cord-301107-0njnjqeb	52	13	1	1	CD
cord-301107-0njnjqeb	52	14	and	and	CC
cord-301107-0njnjqeb	52	15	May	May	NNP
cord-301107-0njnjqeb	52	16	15	15	CD
cord-301107-0njnjqeb	52	17	,	,	,
cord-301107-0njnjqeb	52	18	2020	2020	CD
cord-301107-0njnjqeb	52	19	,	,	,
cord-301107-0njnjqeb	52	20	4	4	CD
cord-301107-0njnjqeb	52	21	patients	patient	NNS
cord-301107-0njnjqeb	52	22	(	(	-LRB-
cord-301107-0njnjqeb	52	23	0.3	0.3	CD
cord-301107-0njnjqeb	52	24	%	%	NN
cord-301107-0njnjqeb	52	25	)	)	-RRB-
cord-301107-0njnjqeb	52	26	were	be	VBD
cord-301107-0njnjqeb	52	27	diagnosed	diagnose	VBN
cord-301107-0njnjqeb	52	28	with	with	IN
cord-301107-0njnjqeb	52	29	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	52	30	disease	disease	NN
cord-301107-0njnjqeb	52	31	.	.	.
cord-301107-0njnjqeb	53	1	After	after	IN
cord-301107-0njnjqeb	53	2	pandemic	pandemic	NN
cord-301107-0njnjqeb	53	3	,	,	,
cord-301107-0njnjqeb	53	4	the	the	DT
cord-301107-0njnjqeb	53	5	number	number	NN
cord-301107-0njnjqeb	53	6	of	of	IN
cord-301107-0njnjqeb	53	7	patients	patient	NNS
cord-301107-0njnjqeb	53	8	with	with	IN
cord-301107-0njnjqeb	53	9	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	53	10	disease	disease	NN
cord-301107-0njnjqeb	53	11	increased	increase	VBD
cord-301107-0njnjqeb	53	12	significantly	significantly	RB
cord-301107-0njnjqeb	53	13	in	in	IN
cord-301107-0njnjqeb	53	14	patients	patient	NNS
cord-301107-0njnjqeb	53	15	who	who	WP
cord-301107-0njnjqeb	53	16	applied	apply	VBD
cord-301107-0njnjqeb	53	17	to	to	IN
cord-301107-0njnjqeb	53	18	the	the	DT
cord-301107-0njnjqeb	53	19	dermatology	dermatology	NN
cord-301107-0njnjqeb	53	20	outpatient	outpatient	NN
cord-301107-0njnjqeb	53	21	clinic	clinic	NN
cord-301107-0njnjqeb	53	22	(	(	-LRB-
cord-301107-0njnjqeb	53	23	p:0,009	p:0,009	NN
cord-301107-0njnjqeb	53	24	)	)	-RRB-
cord-301107-0njnjqeb	53	25	.	.	.
cord-301107-0njnjqeb	54	1	Table	table	NN
cord-301107-0njnjqeb	54	2	2	2	CD
cord-301107-0njnjqeb	54	3	shows	show	VBZ
cord-301107-0njnjqeb	54	4	the	the	DT
cord-301107-0njnjqeb	54	5	distribution	distribution	NN
cord-301107-0njnjqeb	54	6	of	of	IN
cord-301107-0njnjqeb	54	7	patients	patient	NNS
cord-301107-0njnjqeb	54	8	with	with	IN
cord-301107-0njnjqeb	54	9	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	54	10	rosea	rosea	NN
cord-301107-0njnjqeb	54	11	and	and	CC
cord-301107-0njnjqeb	54	12	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	54	13	disease	disease	NN
cord-301107-0njnjqeb	54	14	before	before	RB
cord-301107-0njnjqeb	54	15	and	and	CC
cord-301107-0njnjqeb	54	16	after	after	IN
cord-301107-0njnjqeb	54	17	the	the	DT
cord-301107-0njnjqeb	54	18	pandemic	pandemic	NN
cord-301107-0njnjqeb	54	19	.	.	.
cord-301107-0njnjqeb	55	1	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	55	2	has	have	VBZ
cord-301107-0njnjqeb	55	3	already	already	RB
cord-301107-0njnjqeb	55	4	had	have	VBN
cord-301107-0njnjqeb	55	5	many	many	JJ
cord-301107-0njnjqeb	55	6	effects	effect	NNS
cord-301107-0njnjqeb	55	7	on	on	IN
cord-301107-0njnjqeb	55	8	the	the	DT
cord-301107-0njnjqeb	55	9	routine	routine	JJ
cord-301107-0njnjqeb	55	10	dermatology	dermatology	NN
cord-301107-0njnjqeb	55	11	practice	practice	NN
cord-301107-0njnjqeb	55	12	(	(	-LRB-
cord-301107-0njnjqeb	55	13	5	5	CD
cord-301107-0njnjqeb	55	14	)	)	-RRB-
cord-301107-0njnjqeb	55	15	.	.	.
cord-301107-0njnjqeb	56	1	However	however	RB
cord-301107-0njnjqeb	56	2	,	,	,
cord-301107-0njnjqeb	56	3	it	-PRON-	PRP
cord-301107-0njnjqeb	56	4	is	be	VBZ
cord-301107-0njnjqeb	56	5	clear	clear	JJ
cord-301107-0njnjqeb	56	6	that	that	IN
cord-301107-0njnjqeb	56	7	there	there	EX
cord-301107-0njnjqeb	56	8	will	will	MD
cord-301107-0njnjqeb	56	9	be	be	VB
cord-301107-0njnjqeb	56	10	many	many	JJ
cord-301107-0njnjqeb	56	11	more	more	JJR
cord-301107-0njnjqeb	56	12	developments	development	NNS
cord-301107-0njnjqeb	56	13	and	and	CC
cord-301107-0njnjqeb	56	14	new	new	JJ
cord-301107-0njnjqeb	56	15	information	information	NN
cord-301107-0njnjqeb	56	16	in	in	IN
cord-301107-0njnjqeb	56	17	the	the	DT
cord-301107-0njnjqeb	56	18	relationship	relationship	NN
cord-301107-0njnjqeb	56	19	between	between	IN
cord-301107-0njnjqeb	56	20	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	56	21	and	and	CC
cord-301107-0njnjqeb	56	22	dermatology	dermatology	NN
cord-301107-0njnjqeb	56	23	in	in	IN
cord-301107-0njnjqeb	56	24	the	the	DT
cord-301107-0njnjqeb	56	25	following	follow	VBG
cord-301107-0njnjqeb	56	26	days	day	NNS
cord-301107-0njnjqeb	56	27	.	.	.
cord-301107-0njnjqeb	57	1	SARS	SARS	NNP
cord-301107-0njnjqeb	57	2	-	-	HYPH
cord-301107-0njnjqeb	57	3	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	57	4	,	,	,
cord-301107-0njnjqeb	57	5	which	which	WDT
cord-301107-0njnjqeb	57	6	is	be	VBZ
cord-301107-0njnjqeb	57	7	the	the	DT
cord-301107-0njnjqeb	57	8	cause	cause	NN
cord-301107-0njnjqeb	57	9	of	of	IN
cord-301107-0njnjqeb	57	10	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	57	11	disease	disease	NN
cord-301107-0njnjqeb	57	12	,	,	,
cord-301107-0njnjqeb	57	13	is	be	VBZ
cord-301107-0njnjqeb	57	14	not	not	RB
cord-301107-0njnjqeb	57	15	actually	actually	RB
cord-301107-0njnjqeb	57	16	a	a	DT
cord-301107-0njnjqeb	57	17	dermatotrophic	dermatotrophic	JJ
cord-301107-0njnjqeb	57	18	virus	virus	NN
cord-301107-0njnjqeb	57	19	.	.	.
cord-301107-0njnjqeb	58	1	However	however	RB
cord-301107-0njnjqeb	58	2	,	,	,
cord-301107-0njnjqeb	58	3	various	various	JJ
cord-301107-0njnjqeb	58	4	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	58	5	manifestations	manifestation	NNS
cord-301107-0njnjqeb	58	6	associated	associate	VBN
cord-301107-0njnjqeb	58	7	with	with	IN
cord-301107-0njnjqeb	58	8	the	the	DT
cord-301107-0njnjqeb	58	9	disease	disease	NN
cord-301107-0njnjqeb	58	10	have	have	VBP
cord-301107-0njnjqeb	58	11	been	be	VBN
cord-301107-0njnjqeb	58	12	reported	report	VBN
cord-301107-0njnjqeb	58	13	to	to	TO
cord-301107-0njnjqeb	58	14	develop	develop	VB
cord-301107-0njnjqeb	58	15	during	during	IN
cord-301107-0njnjqeb	58	16	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	58	17	disease	disease	NN
cord-301107-0njnjqeb	58	18	(	(	-LRB-
cord-301107-0njnjqeb	58	19	3	3	CD
cord-301107-0njnjqeb	58	20	,	,	,
cord-301107-0njnjqeb	58	21	6	6	CD
cord-301107-0njnjqeb	58	22	)	)	-RRB-
cord-301107-0njnjqeb	58	23	.	.	.
cord-301107-0njnjqeb	59	1	Cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	59	2	symptoms	symptom	NNS
cord-301107-0njnjqeb	59	3	can	can	MD
cord-301107-0njnjqeb	59	4	be	be	VB
cord-301107-0njnjqeb	59	5	classified	classify	VBN
cord-301107-0njnjqeb	59	6	under	under	IN
cord-301107-0njnjqeb	59	7	five	five	CD
cord-301107-0njnjqeb	59	8	main	main	JJ
cord-301107-0njnjqeb	59	9	categories	category	NNS
cord-301107-0njnjqeb	59	10	(	(	-LRB-
cord-301107-0njnjqeb	59	11	urticarial	urticarial	JJ
cord-301107-0njnjqeb	59	12	lesions	lesion	NNS
cord-301107-0njnjqeb	59	13	,	,	,
cord-301107-0njnjqeb	59	14	livedo	livedo	NN
cord-301107-0njnjqeb	59	15	and	and	CC
cord-301107-0njnjqeb	59	16	necrosis	necrosis	NN
cord-301107-0njnjqeb	59	17	,	,	,
cord-301107-0njnjqeb	59	18	maculopapular	maculopapular	JJ
cord-301107-0njnjqeb	59	19	eruption	eruption	NN
cord-301107-0njnjqeb	59	20	,	,	,
cord-301107-0njnjqeb	59	21	vesicular	vesicular	JJ
cord-301107-0njnjqeb	59	22	rash	rash	NN
cord-301107-0njnjqeb	59	23	,	,	,
cord-301107-0njnjqeb	59	24	pseudo	pseudo	JJ
cord-301107-0njnjqeb	59	25	-	-	JJ
cord-301107-0njnjqeb	59	26	chilblain	chilblain	JJ
cord-301107-0njnjqeb	59	27	)	)	-RRB-
cord-301107-0njnjqeb	59	28	(	(	-LRB-
cord-301107-0njnjqeb	59	29	3	3	CD
cord-301107-0njnjqeb	59	30	)	)	-RRB-
cord-301107-0njnjqeb	59	31	.	.	.
cord-301107-0njnjqeb	60	1	However	however	RB
cord-301107-0njnjqeb	60	2	,	,	,
cord-301107-0njnjqeb	60	3	dermatological	dermatological	JJ
cord-301107-0njnjqeb	60	4	diseases	disease	NNS
cord-301107-0njnjqeb	60	5	triggered	trigger	VBN
cord-301107-0njnjqeb	60	6	by	by	IN
cord-301107-0njnjqeb	60	7	SARS	SARS	NNP
cord-301107-0njnjqeb	60	8	-	-	HYPH
cord-301107-0njnjqeb	60	9	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	60	10	remain	remain	VBP
cord-301107-0njnjqeb	60	11	a	a	DT
cord-301107-0njnjqeb	60	12	mystery	mystery	NN
cord-301107-0njnjqeb	60	13	for	for	IN
cord-301107-0njnjqeb	60	14	now	now	RB
cord-301107-0njnjqeb	60	15	.	.	.
cord-301107-0njnjqeb	61	1	In	in	IN
cord-301107-0njnjqeb	61	2	our	-PRON-	PRP$
cord-301107-0njnjqeb	61	3	study	study	NN
cord-301107-0njnjqeb	61	4	,	,	,
cord-301107-0njnjqeb	61	5	it	-PRON-	PRP
cord-301107-0njnjqeb	61	6	was	be	VBD
cord-301107-0njnjqeb	61	7	found	find	VBN
cord-301107-0njnjqeb	61	8	that	that	IN
cord-301107-0njnjqeb	61	9	the	the	DT
cord-301107-0njnjqeb	61	10	rate	rate	NN
cord-301107-0njnjqeb	61	11	of	of	IN
cord-301107-0njnjqeb	61	12	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	61	13	rosae	rosae	NN
cord-301107-0njnjqeb	61	14	patients	patient	NNS
cord-301107-0njnjqeb	61	15	who	who	WP
cord-301107-0njnjqeb	61	16	applied	apply	VBD
cord-301107-0njnjqeb	61	17	to	to	IN
cord-301107-0njnjqeb	61	18	the	the	DT
cord-301107-0njnjqeb	61	19	dermatology	dermatology	NN
cord-301107-0njnjqeb	61	20	outpatient	outpatient	NN
cord-301107-0njnjqeb	61	21	clinic	clinic	NN
cord-301107-0njnjqeb	61	22	this	this	DT
cord-301107-0njnjqeb	61	23	year	year	NN
cord-301107-0njnjqeb	61	24	during	during	IN
cord-301107-0njnjqeb	61	25	the	the	DT
cord-301107-0njnjqeb	61	26	pandemic	pandemic	NN
cord-301107-0njnjqeb	61	27	period	period	NN
cord-301107-0njnjqeb	61	28	increased	increase	VBD
cord-301107-0njnjqeb	61	29	approximately	approximately	RB
cord-301107-0njnjqeb	61	30	5	5	CD
cord-301107-0njnjqeb	61	31	times	time	NNS
cord-301107-0njnjqeb	61	32	compared	compare	VBN
cord-301107-0njnjqeb	61	33	to	to	IN
cord-301107-0njnjqeb	61	34	the	the	DT
cord-301107-0njnjqeb	61	35	same	same	JJ
cord-301107-0njnjqeb	61	36	time	time	NN
cord-301107-0njnjqeb	61	37	last	last	JJ
cord-301107-0njnjqeb	61	38	year	year	NN
cord-301107-0njnjqeb	61	39	.	.	.
cord-301107-0njnjqeb	62	1	The	the	DT
cord-301107-0njnjqeb	62	2	fact	fact	NN
cord-301107-0njnjqeb	62	3	that	that	IN
cord-301107-0njnjqeb	62	4	there	there	EX
cord-301107-0njnjqeb	62	5	was	be	VBD
cord-301107-0njnjqeb	62	6	no	no	DT
cord-301107-0njnjqeb	62	7	significant	significant	JJ
cord-301107-0njnjqeb	62	8	increase	increase	NN
cord-301107-0njnjqeb	62	9	in	in	IN
cord-301107-0njnjqeb	62	10	the	the	DT
cord-301107-0njnjqeb	62	11	total	total	JJ
cord-301107-0njnjqeb	62	12	number	number	NN
cord-301107-0njnjqeb	62	13	of	of	IN
cord-301107-0njnjqeb	62	14	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	62	15	rosae	rosae	NN
cord-301107-0njnjqeb	62	16	patients	patient	NNS
cord-301107-0njnjqeb	62	17	was	be	VBD
cord-301107-0njnjqeb	62	18	attributed	attribute	VBN
cord-301107-0njnjqeb	62	19	to	to	IN
cord-301107-0njnjqeb	62	20	the	the	DT
cord-301107-0njnjqeb	62	21	low	low	JJ
cord-301107-0njnjqeb	62	22	number	number	NN
cord-301107-0njnjqeb	62	23	of	of	IN
cord-301107-0njnjqeb	62	24	total	total	JJ
cord-301107-0njnjqeb	62	25	admissions	admission	NNS
cord-301107-0njnjqeb	62	26	to	to	IN
cord-301107-0njnjqeb	62	27	the	the	DT
cord-301107-0njnjqeb	62	28	hospital	hospital	NN
cord-301107-0njnjqeb	62	29	during	during	IN
cord-301107-0njnjqeb	62	30	the	the	DT
cord-301107-0njnjqeb	62	31	pandemic	pandemic	NN
cord-301107-0njnjqeb	62	32	period	period	NN
cord-301107-0njnjqeb	62	33	.	.	.
cord-301107-0njnjqeb	63	1	In	in	IN
cord-301107-0njnjqeb	63	2	our	-PRON-	PRP$
cord-301107-0njnjqeb	63	3	opinion	opinion	NN
cord-301107-0njnjqeb	63	4	,	,	,
cord-301107-0njnjqeb	63	5	the	the	DT
cord-301107-0njnjqeb	63	6	increase	increase	NN
cord-301107-0njnjqeb	63	7	in	in	IN
cord-301107-0njnjqeb	63	8	the	the	DT
cord-301107-0njnjqeb	63	9	rate	rate	NN
cord-301107-0njnjqeb	63	10	of	of	IN
cord-301107-0njnjqeb	63	11	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	63	12	rosae	rosae	NN
cord-301107-0njnjqeb	63	13	patients	patient	NNS
cord-301107-0njnjqeb	63	14	among	among	IN
cord-301107-0njnjqeb	63	15	polyclinic	polyclinic	NN
cord-301107-0njnjqeb	63	16	patients	patient	NNS
cord-301107-0njnjqeb	63	17	was	be	VBD
cord-301107-0njnjqeb	63	18	more	more	RBR
cord-301107-0njnjqeb	63	19	important	important	JJ
cord-301107-0njnjqeb	63	20	data	datum	NNS
cord-301107-0njnjqeb	63	21	.	.	.
cord-301107-0njnjqeb	64	1	Previously	previously	RB
cord-301107-0njnjqeb	64	2	,	,	,
cord-301107-0njnjqeb	64	3	A	a	DT
cord-301107-0njnjqeb	64	4	case	case	NN
cord-301107-0njnjqeb	64	5	of	of	IN
cord-301107-0njnjqeb	64	6	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	64	7	rosea	rosea	NN
cord-301107-0njnjqeb	64	8	associated	associate	VBN
cord-301107-0njnjqeb	64	9	with	with	IN
cord-301107-0njnjqeb	64	10	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	64	11	disease	disease	NN
cord-301107-0njnjqeb	64	12	has	have	VBZ
cord-301107-0njnjqeb	64	13	been	be	VBN
cord-301107-0njnjqeb	64	14	reported	report	VBN
cord-301107-0njnjqeb	64	15	(	(	-LRB-
cord-301107-0njnjqeb	64	16	7	7	CD
cord-301107-0njnjqeb	64	17	)	)	-RRB-
cord-301107-0njnjqeb	64	18	.	.	.
cord-301107-0njnjqeb	65	1	Our	-PRON-	PRP$
cord-301107-0njnjqeb	65	2	findings	finding	NNS
cord-301107-0njnjqeb	65	3	are	be	VBP
cord-301107-0njnjqeb	65	4	the	the	DT
cord-301107-0njnjqeb	65	5	first	first	JJ
cord-301107-0njnjqeb	65	6	study	study	NN
cord-301107-0njnjqeb	65	7	in	in	IN
cord-301107-0njnjqeb	65	8	the	the	DT
cord-301107-0njnjqeb	65	9	literature	literature	NN
cord-301107-0njnjqeb	65	10	showing	show	VBG
cord-301107-0njnjqeb	65	11	the	the	DT
cord-301107-0njnjqeb	65	12	increase	increase	NN
cord-301107-0njnjqeb	65	13	of	of	IN
cord-301107-0njnjqeb	65	14	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	65	15	rosea	rosea	NN
cord-301107-0njnjqeb	65	16	patients	patient	NNS
cord-301107-0njnjqeb	65	17	and	and	CC
cord-301107-0njnjqeb	65	18	their	-PRON-	PRP$
cord-301107-0njnjqeb	65	19	relationship	relationship	NN
cord-301107-0njnjqeb	65	20	with	with	IN
cord-301107-0njnjqeb	65	21	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	65	22	.	.	.
cord-301107-0njnjqeb	66	1	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	66	2	rosea	rosea	NN
cord-301107-0njnjqeb	66	3	has	have	VBZ
cord-301107-0njnjqeb	66	4	been	be	VBN
cord-301107-0njnjqeb	66	5	mostly	mostly	RB
cord-301107-0njnjqeb	66	6	associated	associate	VBN
cord-301107-0njnjqeb	66	7	with	with	IN
cord-301107-0njnjqeb	66	8	reactivation	reactivation	NN
cord-301107-0njnjqeb	66	9	of	of	IN
cord-301107-0njnjqeb	66	10	Human	Human	NNP
cord-301107-0njnjqeb	66	11	Herpesvirus	Herpesvirus	NNP
cord-301107-0njnjqeb	66	12	6	6	CD
cord-301107-0njnjqeb	66	13	and	and	CC
cord-301107-0njnjqeb	66	14	7	7	CD
cord-301107-0njnjqeb	66	15	,	,	,
cord-301107-0njnjqeb	66	16	but	but	CC
cord-301107-0njnjqeb	66	17	other	other	JJ
cord-301107-0njnjqeb	66	18	viral	viral	JJ
cord-301107-0njnjqeb	66	19	etiology	etiology	NN
cord-301107-0njnjqeb	66	20	,	,	,
cord-301107-0njnjqeb	66	21	vaccination	vaccination	NN
cord-301107-0njnjqeb	66	22	,	,	,
cord-301107-0njnjqeb	66	23	psychological	psychological	JJ
cord-301107-0njnjqeb	66	24	stress	stress	NN
cord-301107-0njnjqeb	66	25	,	,	,
cord-301107-0njnjqeb	66	26	and	and	CC
cord-301107-0njnjqeb	66	27	drugs	drug	NNS
cord-301107-0njnjqeb	66	28	have	have	VBP
cord-301107-0njnjqeb	66	29	also	also	RB
cord-301107-0njnjqeb	66	30	been	be	VBN
cord-301107-0njnjqeb	66	31	implicated	implicate	VBN
cord-301107-0njnjqeb	66	32	as	as	IN
cord-301107-0njnjqeb	66	33	the	the	DT
cord-301107-0njnjqeb	66	34	cause	cause	NN
cord-301107-0njnjqeb	66	35	of	of	IN
cord-301107-0njnjqeb	66	36	this	this	DT
cord-301107-0njnjqeb	66	37	reaction	reaction	NN
cord-301107-0njnjqeb	66	38	(	(	-LRB-
cord-301107-0njnjqeb	66	39	8)	8)	NN
cord-301107-0njnjqeb	66	40	.	.	.
cord-301107-0njnjqeb	67	1	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	67	2	,	,	,
cord-301107-0njnjqeb	67	3	a	a	DT
cord-301107-0njnjqeb	67	4	member	member	NN
cord-301107-0njnjqeb	67	5	of	of	IN
cord-301107-0njnjqeb	67	6	the	the	DT
cord-301107-0njnjqeb	67	7	herpes	herpes	NNP
cord-301107-0njnjqeb	67	8	virus	virus	NN
cord-301107-0njnjqeb	67	9	family	family	NN
cord-301107-0njnjqeb	67	10	,	,	,
cord-301107-0njnjqeb	67	11	is	be	VBZ
cord-301107-0njnjqeb	67	12	usually	usually	RB
cord-301107-0njnjqeb	67	13	transmitted	transmit	VBN
cord-301107-0njnjqeb	67	14	in	in	IN
cord-301107-0njnjqeb	67	15	the	the	DT
cord-301107-0njnjqeb	67	16	first	first	JJ
cord-301107-0njnjqeb	67	17	two	two	CD
cord-301107-0njnjqeb	67	18	years	year	NNS
cord-301107-0njnjqeb	67	19	of	of	IN
cord-301107-0njnjqeb	67	20	life	life	NN
cord-301107-0njnjqeb	67	21	(	(	-LRB-
cord-301107-0njnjqeb	67	22	Roseola	Roseola	NNP
cord-301107-0njnjqeb	67	23	infantum	infantum	NNP
cord-301107-0njnjqeb	67	24	)	)	-RRB-
cord-301107-0njnjqeb	67	25	and	and	CC
cord-301107-0njnjqeb	67	26	settles	settle	VBZ
cord-301107-0njnjqeb	67	27	in	in	IN
cord-301107-0njnjqeb	67	28	the	the	DT
cord-301107-0njnjqeb	67	29	salivary	salivary	NN
cord-301107-0njnjqeb	67	30	glands	gland	NNS
cord-301107-0njnjqeb	67	31	,	,	,
cord-301107-0njnjqeb	67	32	causing	cause	VBG
cord-301107-0njnjqeb	67	33	a	a	DT
cord-301107-0njnjqeb	67	34	latent	latent	JJ
cord-301107-0njnjqeb	67	35	infection	infection	NN
cord-301107-0njnjqeb	67	36	(	(	-LRB-
cord-301107-0njnjqeb	67	37	9	9	CD
cord-301107-0njnjqeb	67	38	)	)	-RRB-
cord-301107-0njnjqeb	67	39	.	.	.
cord-301107-0njnjqeb	68	1	There	there	EX
cord-301107-0njnjqeb	68	2	are	be	VBP
cord-301107-0njnjqeb	68	3	two	two	CD
cord-301107-0njnjqeb	68	4	types	type	NNS
cord-301107-0njnjqeb	68	5	of	of	IN
cord-301107-0njnjqeb	68	6	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	68	7	,	,	,
cord-301107-0njnjqeb	68	8	A	A	NNP
cord-301107-0njnjqeb	68	9	and	and	CC
cord-301107-0njnjqeb	68	10	B	B	NNP
cord-301107-0njnjqeb	68	11	(	(	-LRB-
cord-301107-0njnjqeb	68	12	10	10	CD
cord-301107-0njnjqeb	68	13	)	)	-RRB-
cord-301107-0njnjqeb	68	14	.	.	.
cord-301107-0njnjqeb	69	1	The	the	DT
cord-301107-0njnjqeb	69	2	reactivation	reactivation	NN
cord-301107-0njnjqeb	69	3	of	of	IN
cord-301107-0njnjqeb	69	4	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	69	5	is	be	VBZ
cord-301107-0njnjqeb	69	6	blamed	blame	VBN
cord-301107-0njnjqeb	69	7	for	for	IN
cord-301107-0njnjqeb	69	8	many	many	JJ
cord-301107-0njnjqeb	69	9	diseases	disease	NNS
cord-301107-0njnjqeb	69	10	,	,	,
cord-301107-0njnjqeb	69	11	including	include	VBG
cord-301107-0njnjqeb	69	12	Pitriasis	Pitriasis	NNP
cord-301107-0njnjqeb	69	13	rosae	rosae	NNP
cord-301107-0njnjqeb	69	14	(	(	-LRB-
cord-301107-0njnjqeb	69	15	11	11	CD
cord-301107-0njnjqeb	69	16	)	)	-RRB-
cord-301107-0njnjqeb	69	17	.	.	.
cord-301107-0njnjqeb	70	1	It	-PRON-	PRP
cord-301107-0njnjqeb	70	2	has	have	VBZ
cord-301107-0njnjqeb	70	3	been	be	VBN
cord-301107-0njnjqeb	70	4	argued	argue	VBN
cord-301107-0njnjqeb	70	5	that	that	IN
cord-301107-0njnjqeb	70	6	one	one	CD
cord-301107-0njnjqeb	70	7	of	of	IN
cord-301107-0njnjqeb	70	8	the	the	DT
cord-301107-0njnjqeb	70	9	factors	factor	NNS
cord-301107-0njnjqeb	70	10	causing	cause	VBG
cord-301107-0njnjqeb	70	11	activation	activation	NN
cord-301107-0njnjqeb	70	12	of	of	IN
cord-301107-0njnjqeb	70	13	Herpes	Herpes	NNP
cord-301107-0njnjqeb	70	14	viruses	virus	NNS
cord-301107-0njnjqeb	70	15	is	be	VBZ
cord-301107-0njnjqeb	70	16	coronaviruses	coronaviruse	NNS
cord-301107-0njnjqeb	70	17	(	(	-LRB-
cord-301107-0njnjqeb	70	18	12	12	CD
cord-301107-0njnjqeb	70	19	)	)	-RRB-
cord-301107-0njnjqeb	70	20	.	.	.
cord-301107-0njnjqeb	71	1	Along	along	IN
cord-301107-0njnjqeb	71	2	with	with	IN
cord-301107-0njnjqeb	71	3	the	the	DT
cord-301107-0njnjqeb	71	4	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	71	5	Pandemic	Pandemic	NNP
cord-301107-0njnjqeb	71	6	,	,	,
cord-301107-0njnjqeb	71	7	it	-PRON-	PRP
cord-301107-0njnjqeb	71	8	was	be	VBD
cord-301107-0njnjqeb	71	9	thought	think	VBN
cord-301107-0njnjqeb	71	10	that	that	IN
cord-301107-0njnjqeb	71	11	reactivation	reactivation	NN
cord-301107-0njnjqeb	71	12	of	of	IN
cord-301107-0njnjqeb	71	13	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	71	14	could	could	MD
cord-301107-0njnjqeb	71	15	explain	explain	VB
cord-301107-0njnjqeb	71	16	this	this	DT
cord-301107-0njnjqeb	71	17	obvious	obvious	JJ
cord-301107-0njnjqeb	71	18	increase	increase	NN
cord-301107-0njnjqeb	71	19	in	in	IN
cord-301107-0njnjqeb	71	20	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	71	21	rosea	rosea	NN
cord-301107-0njnjqeb	71	22	cases	case	NNS
cord-301107-0njnjqeb	71	23	.	.	.
cord-301107-0njnjqeb	72	1	Another	another	DT
cord-301107-0njnjqeb	72	2	possible	possible	JJ
cord-301107-0njnjqeb	72	3	trigger	trigger	NN
cord-301107-0njnjqeb	72	4	could	could	MD
cord-301107-0njnjqeb	72	5	be	be	VB
cord-301107-0njnjqeb	72	6	psychological	psychological	JJ
cord-301107-0njnjqeb	72	7	stress	stress	NN
cord-301107-0njnjqeb	72	8	caused	cause	VBN
cord-301107-0njnjqeb	72	9	by	by	IN
cord-301107-0njnjqeb	72	10	the	the	DT
cord-301107-0njnjqeb	72	11	pandemic	pandemic	NN
cord-301107-0njnjqeb	72	12	period	period	NN
cord-301107-0njnjqeb	72	13	.	.	.
cord-301107-0njnjqeb	73	1	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	73	2	disease	disease	NN
cord-301107-0njnjqeb	73	3	is	be	VBZ
cord-301107-0njnjqeb	73	4	a	a	DT
cord-301107-0njnjqeb	73	5	systemic	systemic	JJ
cord-301107-0njnjqeb	73	6	vasculitis	vasculitis	NN
cord-301107-0njnjqeb	73	7	of	of	IN
cord-301107-0njnjqeb	73	8	childhood	childhood	NN
cord-301107-0njnjqeb	73	9	that	that	WDT
cord-301107-0njnjqeb	73	10	can	can	MD
cord-301107-0njnjqeb	73	11	affect	affect	VB
cord-301107-0njnjqeb	73	12	the	the	DT
cord-301107-0njnjqeb	73	13	coronary	coronary	JJ
cord-301107-0njnjqeb	73	14	arteries	artery	NNS
cord-301107-0njnjqeb	73	15	.	.	.
cord-301107-0njnjqeb	74	1	The	the	DT
cord-301107-0njnjqeb	74	2	diagnosis	diagnosis	NN
cord-301107-0njnjqeb	74	3	of	of	IN
cord-301107-0njnjqeb	74	4	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	74	5	disease	disease	NN
cord-301107-0njnjqeb	74	6	is	be	VBZ
cord-301107-0njnjqeb	74	7	based	base	VBN
cord-301107-0njnjqeb	74	8	on	on	IN
cord-301107-0njnjqeb	74	9	clinical	clinical	JJ
cord-301107-0njnjqeb	74	10	features	feature	NNS
cord-301107-0njnjqeb	74	11	.	.	.
cord-301107-0njnjqeb	75	1	Cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	75	2	symptoms	symptom	NNS
cord-301107-0njnjqeb	75	3	with	with	IN
cord-301107-0njnjqeb	75	4	diagnostic	diagnostic	JJ
cord-301107-0njnjqeb	75	5	criteria	criterion	NNS
cord-301107-0njnjqeb	75	6	are	be	VBP
cord-301107-0njnjqeb	75	7	:	:	:
cord-301107-0njnjqeb	75	8	Erythema	erythema	NN
cord-301107-0njnjqeb	75	9	of	of	IN
cord-301107-0njnjqeb	75	10	the	the	DT
cord-301107-0njnjqeb	75	11	mouth	mouth	NN
cord-301107-0njnjqeb	75	12	or	or	CC
cord-301107-0njnjqeb	75	13	pharynx	pharynx	NN
cord-301107-0njnjqeb	75	14	,	,	,
cord-301107-0njnjqeb	75	15	strawberry	strawberry	JJ
cord-301107-0njnjqeb	75	16	tongue	tongue	NN
cord-301107-0njnjqeb	75	17	,	,	,
cord-301107-0njnjqeb	75	18	or	or	CC
cord-301107-0njnjqeb	75	19	stomatitis	stomatitis	NN
cord-301107-0njnjqeb	75	20	;	;	:
cord-301107-0njnjqeb	75	21	polymorphous	polymorphous	JJ
cord-301107-0njnjqeb	75	22	rash	rash	NN
cord-301107-0njnjqeb	75	23	;	;	:
cord-301107-0njnjqeb	75	24	erythema	erythema	NN
cord-301107-0njnjqeb	75	25	or	or	CC
cord-301107-0njnjqeb	75	26	edema	edema	NN
cord-301107-0njnjqeb	75	27	of	of	IN
cord-301107-0njnjqeb	75	28	the	the	DT
cord-301107-0njnjqeb	75	29	hands	hand	NNS
cord-301107-0njnjqeb	75	30	or	or	CC
cord-301107-0njnjqeb	75	31	feet	foot	NNS
cord-301107-0njnjqeb	75	32	(	(	-LRB-
cord-301107-0njnjqeb	75	33	13	13	CD
cord-301107-0njnjqeb	75	34	)	)	-RRB-
cord-301107-0njnjqeb	75	35	.	.	.
cord-301107-0njnjqeb	76	1	The	the	DT
cord-301107-0njnjqeb	76	2	etiology	etiology	NN
cord-301107-0njnjqeb	76	3	of	of	IN
cord-301107-0njnjqeb	76	4	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	76	5	disease	disease	NN
cord-301107-0njnjqeb	76	6	is	be	VBZ
cord-301107-0njnjqeb	76	7	still	still	RB
cord-301107-0njnjqeb	76	8	unknown	unknown	JJ
cord-301107-0njnjqeb	76	9	.	.	.
cord-301107-0njnjqeb	77	1	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	77	2	is	be	VBZ
cord-301107-0njnjqeb	77	3	one	one	CD
cord-301107-0njnjqeb	77	4	of	of	IN
cord-301107-0njnjqeb	77	5	the	the	DT
cord-301107-0njnjqeb	77	6	accused	accuse	VBN
cord-301107-0njnjqeb	77	7	reasons	reason	NNS
cord-301107-0njnjqeb	77	8	for	for	IN
cord-301107-0njnjqeb	77	9	the	the	DT
cord-301107-0njnjqeb	77	10	etiology	etiology	NN
cord-301107-0njnjqeb	77	11	(	(	-LRB-
cord-301107-0njnjqeb	77	12	14	14	CD
cord-301107-0njnjqeb	77	13	)	)	-RRB-
cord-301107-0njnjqeb	77	14	.	.	.
cord-301107-0njnjqeb	78	1	In	in	IN
cord-301107-0njnjqeb	78	2	a	a	DT
cord-301107-0njnjqeb	78	3	study	study	NN
cord-301107-0njnjqeb	78	4	conducted	conduct	VBN
cord-301107-0njnjqeb	78	5	during	during	IN
cord-301107-0njnjqeb	78	6	the	the	DT
cord-301107-0njnjqeb	78	7	COVID-19	covid-19	JJ
cord-301107-0njnjqeb	78	8	pandemic	pandemic	NN
cord-301107-0njnjqeb	78	9	,	,	,
cord-301107-0njnjqeb	78	10	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	78	11	disease	disease	NN
cord-301107-0njnjqeb	78	12	was	be	VBD
cord-301107-0njnjqeb	78	13	found	find	VBN
cord-301107-0njnjqeb	78	14	to	to	TO
cord-301107-0njnjqeb	78	15	increase	increase	VB
cord-301107-0njnjqeb	78	16	30-fold	30-fold	IN
cord-301107-0njnjqeb	78	17	compared	compare	VBN
cord-301107-0njnjqeb	78	18	to	to	IN
cord-301107-0njnjqeb	78	19	previous	previous	JJ
cord-301107-0njnjqeb	78	20	years	year	NNS
cord-301107-0njnjqeb	78	21	(	(	-LRB-
cord-301107-0njnjqeb	78	22	15	15	CD
cord-301107-0njnjqeb	78	23	)	)	-RRB-
cord-301107-0njnjqeb	78	24	.	.	.
cord-301107-0njnjqeb	79	1	In	in	IN
cord-301107-0njnjqeb	79	2	our	-PRON-	PRP$
cord-301107-0njnjqeb	79	3	study	study	NN
cord-301107-0njnjqeb	79	4	,	,	,
cord-301107-0njnjqeb	79	5	there	there	EX
cord-301107-0njnjqeb	79	6	was	be	VBD
cord-301107-0njnjqeb	79	7	a	a	DT
cord-301107-0njnjqeb	79	8	10-fold	10-fold	JJ
cord-301107-0njnjqeb	79	9	increase	increase	NN
cord-301107-0njnjqeb	79	10	in	in	IN
cord-301107-0njnjqeb	79	11	the	the	DT
cord-301107-0njnjqeb	79	12	rate	rate	NN
cord-301107-0njnjqeb	79	13	of	of	IN
cord-301107-0njnjqeb	79	14	patients	patient	NNS
cord-301107-0njnjqeb	79	15	with	with	IN
cord-301107-0njnjqeb	79	16	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	79	17	disease	disease	NN
cord-301107-0njnjqeb	79	18	who	who	WP
cord-301107-0njnjqeb	79	19	applied	apply	VBD
cord-301107-0njnjqeb	79	20	to	to	IN
cord-301107-0njnjqeb	79	21	the	the	DT
cord-301107-0njnjqeb	79	22	dermatology	dermatology	NN
cord-301107-0njnjqeb	79	23	outpatient	outpatient	NN
cord-301107-0njnjqeb	79	24	clinic	clinic	NN
cord-301107-0njnjqeb	79	25	compared	compare	VBN
cord-301107-0njnjqeb	79	26	to	to	IN
cord-301107-0njnjqeb	79	27	the	the	DT
cord-301107-0njnjqeb	79	28	previous	previous	JJ
cord-301107-0njnjqeb	79	29	year	year	NN
cord-301107-0njnjqeb	79	30	.	.	.
cord-301107-0njnjqeb	80	1	We	-PRON-	PRP
cord-301107-0njnjqeb	80	2	think	think	VBP
cord-301107-0njnjqeb	80	3	that	that	IN
cord-301107-0njnjqeb	80	4	this	this	DT
cord-301107-0njnjqeb	80	5	increase	increase	NN
cord-301107-0njnjqeb	80	6	in	in	IN
cord-301107-0njnjqeb	80	7	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	80	8	disease	disease	NN
cord-301107-0njnjqeb	80	9	during	during	IN
cord-301107-0njnjqeb	80	10	the	the	DT
cord-301107-0njnjqeb	80	11	COVID-19	covid-19	JJ
cord-301107-0njnjqeb	80	12	pandemic	pandemic	NN
cord-301107-0njnjqeb	80	13	may	may	MD
cord-301107-0njnjqeb	80	14	be	be	VB
cord-301107-0njnjqeb	80	15	due	due	JJ
cord-301107-0njnjqeb	80	16	to	to	IN
cord-301107-0njnjqeb	80	17	coronavirus	coronavirus	NN
cord-301107-0njnjqeb	80	18	triggering	trigger	VBG
cord-301107-0njnjqeb	80	19	of	of	IN
cord-301107-0njnjqeb	80	20	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	80	21	,	,	,
cord-301107-0njnjqeb	80	22	which	which	WDT
cord-301107-0njnjqeb	80	23	is	be	VBZ
cord-301107-0njnjqeb	80	24	responsible	responsible	JJ
cord-301107-0njnjqeb	80	25	for	for	IN
cord-301107-0njnjqeb	80	26	the	the	DT
cord-301107-0njnjqeb	80	27	etiology	etiology	NN
cord-301107-0njnjqeb	80	28	.	.	.
cord-301107-0njnjqeb	81	1	The	the	DT
cord-301107-0njnjqeb	81	2	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	81	3	disease	disease	NN
cord-301107-0njnjqeb	81	4	caused	cause	VBN
cord-301107-0njnjqeb	81	5	by	by	IN
cord-301107-0njnjqeb	81	6	SARS	SARS	NNP
cord-301107-0njnjqeb	81	7	-	-	HYPH
cord-301107-0njnjqeb	81	8	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	81	9	still	still	RB
cord-301107-0njnjqeb	81	10	contains	contain	VBZ
cord-301107-0njnjqeb	81	11	great	great	JJ
cord-301107-0njnjqeb	81	12	mysteries	mystery	NNS
cord-301107-0njnjqeb	81	13	for	for	IN
cord-301107-0njnjqeb	81	14	dermatology	dermatology	NN
cord-301107-0njnjqeb	81	15	.	.	.
cord-301107-0njnjqeb	82	1	In	in	IN
cord-301107-0njnjqeb	82	2	order	order	NN
cord-301107-0njnjqeb	82	3	to	to	TO
cord-301107-0njnjqeb	82	4	solve	solve	VB
cord-301107-0njnjqeb	82	5	the	the	DT
cord-301107-0njnjqeb	82	6	mysteries	mystery	NNS
cord-301107-0njnjqeb	82	7	about	about	IN
cord-301107-0njnjqeb	82	8	the	the	DT
cord-301107-0njnjqeb	82	9	disease	disease	NN
cord-301107-0njnjqeb	82	10	,	,	,
cord-301107-0njnjqeb	82	11	a	a	DT
cord-301107-0njnjqeb	82	12	lot	lot	NN
cord-301107-0njnjqeb	82	13	of	of	IN
cord-301107-0njnjqeb	82	14	data	datum	NNS
cord-301107-0njnjqeb	82	15	are	be	VBP
cord-301107-0njnjqeb	82	16	published	publish	VBN
cord-301107-0njnjqeb	82	17	about	about	IN
cord-301107-0njnjqeb	82	18	the	the	DT
cord-301107-0njnjqeb	82	19	clinical	clinical	JJ
cord-301107-0njnjqeb	82	20	symptoms	symptom	NNS
cord-301107-0njnjqeb	82	21	caused	cause	VBN
cord-301107-0njnjqeb	82	22	by	by	IN
cord-301107-0njnjqeb	82	23	the	the	DT
cord-301107-0njnjqeb	82	24	disease	disease	NN
cord-301107-0njnjqeb	82	25	,	,	,
cord-301107-0njnjqeb	82	26	the	the	DT
cord-301107-0njnjqeb	82	27	effects	effect	NNS
cord-301107-0njnjqeb	82	28	and	and	CC
cord-301107-0njnjqeb	82	29	side	side	NN
cord-301107-0njnjqeb	82	30	effects	effect	NNS
cord-301107-0njnjqeb	82	31	of	of	IN
cord-301107-0njnjqeb	82	32	drug	drug	NN
cord-301107-0njnjqeb	82	33	treatments	treatment	NNS
cord-301107-0njnjqeb	82	34	,	,	,
cord-301107-0njnjqeb	82	35	and	and	CC
cord-301107-0njnjqeb	82	36	the	the	DT
cord-301107-0njnjqeb	82	37	associated	associate	VBN
cord-301107-0njnjqeb	82	38	diseases	disease	NNS
cord-301107-0njnjqeb	82	39	.	.	.
cord-301107-0njnjqeb	83	1	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	83	2	disease	disease	NN
cord-301107-0njnjqeb	83	3	has	have	VBZ
cord-301107-0njnjqeb	83	4	been	be	VBN
cord-301107-0njnjqeb	83	5	reported	report	VBN
cord-301107-0njnjqeb	83	6	to	to	TO
cord-301107-0njnjqeb	83	7	increase	increase	VB
cord-301107-0njnjqeb	83	8	compared	compare	VBN
cord-301107-0njnjqeb	83	9	to	to	IN
cord-301107-0njnjqeb	83	10	previous	previous	JJ
cord-301107-0njnjqeb	83	11	years	year	NNS
cord-301107-0njnjqeb	83	12	.	.	.
cord-301107-0njnjqeb	84	1	However	however	RB
cord-301107-0njnjqeb	84	2	,	,	,
cord-301107-0njnjqeb	84	3	there	there	EX
cord-301107-0njnjqeb	84	4	is	be	VBZ
cord-301107-0njnjqeb	84	5	no	no	DT
cord-301107-0njnjqeb	84	6	data	data	NN
cord-301107-0njnjqeb	84	7	to	to	TO
cord-301107-0njnjqeb	84	8	show	show	VB
cord-301107-0njnjqeb	84	9	the	the	DT
cord-301107-0njnjqeb	84	10	increase	increase	NN
cord-301107-0njnjqeb	84	11	of	of	IN
cord-301107-0njnjqeb	84	12	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	84	13	rosae	rosae	NN
cord-301107-0njnjqeb	84	14	patients	patient	NNS
cord-301107-0njnjqeb	84	15	in	in	IN
cord-301107-0njnjqeb	84	16	which	which	WDT
cord-301107-0njnjqeb	84	17	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	84	18	plays	play	VBZ
cord-301107-0njnjqeb	84	19	a	a	DT
cord-301107-0njnjqeb	84	20	role	role	NN
cord-301107-0njnjqeb	84	21	in	in	IN
cord-301107-0njnjqeb	84	22	etiopathogenesis	etiopathogenesis	NN
cord-301107-0njnjqeb	84	23	,	,	,
cord-301107-0njnjqeb	84	24	as	as	IN
cord-301107-0njnjqeb	84	25	in	in	IN
cord-301107-0njnjqeb	84	26	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	84	27	disease	disease	NN
cord-301107-0njnjqeb	84	28	.	.	.
cord-301107-0njnjqeb	85	1	Our	-PRON-	PRP$
cord-301107-0njnjqeb	85	2	study	study	NN
cord-301107-0njnjqeb	85	3	is	be	VBZ
cord-301107-0njnjqeb	85	4	the	the	DT
cord-301107-0njnjqeb	85	5	first	first	JJ
cord-301107-0njnjqeb	85	6	study	study	NN
cord-301107-0njnjqeb	85	7	showing	show	VBG
cord-301107-0njnjqeb	85	8	pityriasis	pityriasis	NN
cord-301107-0njnjqeb	85	9	rosea	rosea	NN
cord-301107-0njnjqeb	85	10	increase	increase	NN
cord-301107-0njnjqeb	85	11	during	during	IN
cord-301107-0njnjqeb	85	12	pandemic	pandemic	JJ
cord-301107-0njnjqeb	85	13	period	period	NN
cord-301107-0njnjqeb	85	14	.	.	.
cord-301107-0njnjqeb	86	1	We	-PRON-	PRP
cord-301107-0njnjqeb	86	2	think	think	VBP
cord-301107-0njnjqeb	86	3	that	that	IN
cord-301107-0njnjqeb	86	4	this	this	DT
cord-301107-0njnjqeb	86	5	increase	increase	NN
cord-301107-0njnjqeb	86	6	is	be	VBZ
cord-301107-0njnjqeb	86	7	related	relate	VBN
cord-301107-0njnjqeb	86	8	to	to	IN
cord-301107-0njnjqeb	86	9	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	86	10	reactivation	reactivation	NN
cord-301107-0njnjqeb	86	11	.	.	.
cord-301107-0njnjqeb	87	1	Herein	herein	RB
cord-301107-0njnjqeb	87	2	,	,	,
cord-301107-0njnjqeb	87	3	we	-PRON-	PRP
cord-301107-0njnjqeb	87	4	wanted	want	VBD
cord-301107-0njnjqeb	87	5	to	to	TO
cord-301107-0njnjqeb	87	6	draw	draw	VB
cord-301107-0njnjqeb	87	7	attention	attention	NN
cord-301107-0njnjqeb	87	8	to	to	IN
cord-301107-0njnjqeb	87	9	two	two	CD
cord-301107-0njnjqeb	87	10	diseases	disease	NNS
cord-301107-0njnjqeb	87	11	in	in	IN
cord-301107-0njnjqeb	87	12	which	which	WDT
cord-301107-0njnjqeb	87	13	Human	Human	NNP
cord-301107-0njnjqeb	87	14	Herpes	Herpes	NNP
cord-301107-0njnjqeb	87	15	6	6	CD
cord-301107-0njnjqeb	87	16	(	(	-LRB-
cord-301107-0njnjqeb	87	17	HHV-6	HHV-6	NNP
cord-301107-0njnjqeb	87	18	)	)	-RRB-
cord-301107-0njnjqeb	87	19	was	be	VBD
cord-301107-0njnjqeb	87	20	accused	accuse	VBN
cord-301107-0njnjqeb	87	21	in	in	IN
cord-301107-0njnjqeb	87	22	etiopathogenesis	etiopathogenesis	NN
cord-301107-0njnjqeb	87	23	:	:	:
cord-301107-0njnjqeb	87	24	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	87	25	disease	disease	NN
cord-301107-0njnjqeb	87	26	and	and	CC
cord-301107-0njnjqeb	87	27	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	87	28	rosea	rosea	NN
cord-301107-0njnjqeb	87	29	.	.	.
cord-301107-0njnjqeb	87	30	 	 	_SP
cord-301107-0njnjqeb	88	1	Genomic	genomic	JJ
cord-301107-0njnjqeb	88	2	characterisation	characterisation	NN
cord-301107-0njnjqeb	88	3	and	and	CC
cord-301107-0njnjqeb	88	4	epidemiology	epidemiology	NN
cord-301107-0njnjqeb	88	5	of	of	IN
cord-301107-0njnjqeb	88	6	2019	2019	CD
cord-301107-0njnjqeb	88	7	novel	novel	JJ
cord-301107-0njnjqeb	88	8	coronavirus	coronavirus	NN
cord-301107-0njnjqeb	88	9	:	:	:
cord-301107-0njnjqeb	88	10	implications	implication	NNS
cord-301107-0njnjqeb	88	11	for	for	IN
cord-301107-0njnjqeb	88	12	virus	virus	NN
cord-301107-0njnjqeb	88	13	origins	origin	NNS
cord-301107-0njnjqeb	88	14	and	and	CC
cord-301107-0njnjqeb	88	15	receptor	receptor	NN
cord-301107-0njnjqeb	88	16	binding	bind	VBG
cord-301107-0njnjqeb	88	17	Clinical	clinical	JJ
cord-301107-0njnjqeb	88	18	characteristics	characteristic	NNS
cord-301107-0njnjqeb	88	19	of	of	IN
cord-301107-0njnjqeb	88	20	2019	2019	CD
cord-301107-0njnjqeb	88	21	novel	novel	JJ
cord-301107-0njnjqeb	88	22	coronavirus	coronavirus	NN
cord-301107-0njnjqeb	88	23	infection	infection	NN
cord-301107-0njnjqeb	88	24	in	in	IN
cord-301107-0njnjqeb	88	25	China	China	NNP
cord-301107-0njnjqeb	88	26	Classification	Classification	NNP
cord-301107-0njnjqeb	88	27	of	of	IN
cord-301107-0njnjqeb	88	28	the	the	DT
cord-301107-0njnjqeb	88	29	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	88	30	manifestations	manifestation	NNS
cord-301107-0njnjqeb	88	31	of	of	IN
cord-301107-0njnjqeb	88	32	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	88	33	:	:	:
cord-301107-0njnjqeb	88	34	a	a	DT
cord-301107-0njnjqeb	88	35	rapid	rapid	JJ
cord-301107-0njnjqeb	88	36	prospective	prospective	JJ
cord-301107-0njnjqeb	88	37	nationwide	nationwide	JJ
cord-301107-0njnjqeb	88	38	consensus	consensus	NN
cord-301107-0njnjqeb	88	39	study	study	NN
cord-301107-0njnjqeb	88	40	in	in	IN
cord-301107-0njnjqeb	88	41	Spain	Spain	NNP
cord-301107-0njnjqeb	88	42	with	with	IN
cord-301107-0njnjqeb	88	43	375	375	CD
cord-301107-0njnjqeb	88	44	cases	case	NNS
cord-301107-0njnjqeb	88	45	Viral	viral	JJ
cord-301107-0njnjqeb	88	46	exanthem	exanthem	NN
cord-301107-0njnjqeb	88	47	in	in	IN
cord-301107-0njnjqeb	88	48	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	88	49	,	,	,
cord-301107-0njnjqeb	88	50	a	a	DT
cord-301107-0njnjqeb	88	51	clinical	clinical	JJ
cord-301107-0njnjqeb	88	52	enigma	enigma	NN
cord-301107-0njnjqeb	88	53	with	with	IN
cord-301107-0njnjqeb	88	54	biological	biological	JJ
cord-301107-0njnjqeb	88	55	significance	significance	NN
cord-301107-0njnjqeb	88	56	Evaluation	Evaluation	NNP
cord-301107-0njnjqeb	88	57	Of	of	IN
cord-301107-0njnjqeb	88	58	Dermatology	Dermatology	NNP
cord-301107-0njnjqeb	88	59	Consultations	consultation	NNS
cord-301107-0njnjqeb	89	1	In	in	IN
cord-301107-0njnjqeb	89	2	The	the	DT
cord-301107-0njnjqeb	89	3	Era	era	NN
cord-301107-0njnjqeb	89	4	Of	of	IN
cord-301107-0njnjqeb	89	5	COVID19	covid19	NN
cord-301107-0njnjqeb	89	6	Cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	89	7	manifestations	manifestation	NNS
cord-301107-0njnjqeb	89	8	in	in	IN
cord-301107-0njnjqeb	89	9	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	89	10	:	:	:
cord-301107-0njnjqeb	89	11	a	a	DT
cord-301107-0njnjqeb	89	12	new	new	JJ
cord-301107-0njnjqeb	89	13	contribution	contribution	NN
cord-301107-0njnjqeb	89	14	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	89	15	rosea	rosea	NN
cord-301107-0njnjqeb	89	16	as	as	IN
cord-301107-0njnjqeb	89	17	a	a	DT
cord-301107-0njnjqeb	89	18	cutaneous	cutaneous	JJ
cord-301107-0njnjqeb	89	19	manifestation	manifestation	NN
cord-301107-0njnjqeb	89	20	of	of	IN
cord-301107-0njnjqeb	89	21	COVID-19	covid-19	JJ
cord-301107-0njnjqeb	89	22	infection	infection	NN
cord-301107-0njnjqeb	89	23	Pityriasis	pityriasis	NN
cord-301107-0njnjqeb	89	24	rosea	rosea	NN
cord-301107-0njnjqeb	89	25	recurrence	recurrence	NN
cord-301107-0njnjqeb	89	26	is	be	VBZ
cord-301107-0njnjqeb	89	27	much	much	RB
cord-301107-0njnjqeb	89	28	higher	high	JJR
cord-301107-0njnjqeb	89	29	than	than	IN
cord-301107-0njnjqeb	89	30	previously	previously	RB
cord-301107-0njnjqeb	89	31	known	know	VBN
cord-301107-0njnjqeb	89	32	:	:	:
cord-301107-0njnjqeb	89	33	a	a	DT
cord-301107-0njnjqeb	89	34	prospective	prospective	JJ
cord-301107-0njnjqeb	89	35	study	study	NN
cord-301107-0njnjqeb	89	36	Molecular	molecular	JJ
cord-301107-0njnjqeb	89	37	epidemiological	epidemiological	JJ
cord-301107-0njnjqeb	89	38	studies	study	NNS
cord-301107-0njnjqeb	89	39	of	of	IN
cord-301107-0njnjqeb	89	40	human	human	JJ
cord-301107-0njnjqeb	89	41	herpesvirus	herpesvirus	NNP
cord-301107-0njnjqeb	89	42	6	6	CD
cord-301107-0njnjqeb	89	43	in	in	IN
cord-301107-0njnjqeb	89	44	families	family	NNS
cord-301107-0njnjqeb	90	1	A	a	DT
cord-301107-0njnjqeb	90	2	populationbased	populationbased	JJ
cord-301107-0njnjqeb	90	3	study	study	NN
cord-301107-0njnjqeb	90	4	of	of	IN
cord-301107-0njnjqeb	90	5	primary	primary	JJ
cord-301107-0njnjqeb	90	6	human	human	JJ
cord-301107-0njnjqeb	90	7	herpesvirus	herpesvirus	NN
cord-301107-0njnjqeb	90	8	6	6	CD
cord-301107-0njnjqeb	90	9	infection	infection	NN
cord-301107-0njnjqeb	91	1	Additional	additional	JJ
cord-301107-0njnjqeb	91	2	evidence	evidence	NN
cord-301107-0njnjqeb	91	3	that	that	IN
cord-301107-0njnjqeb	91	4	pityriasis	pityriasis	NN
cord-301107-0njnjqeb	91	5	rosea	rosea	NN
cord-301107-0njnjqeb	91	6	is	be	VBZ
cord-301107-0njnjqeb	91	7	associated	associate	VBN
cord-301107-0njnjqeb	91	8	with	with	IN
cord-301107-0njnjqeb	91	9	reactivation	reactivation	NN
cord-301107-0njnjqeb	91	10	of	of	IN
cord-301107-0njnjqeb	91	11	human	human	JJ
cord-301107-0njnjqeb	91	12	herpesvirus-6	herpesvirus-6	NNP
cord-301107-0njnjqeb	91	13	and-7	and-7	.
cord-301107-0njnjqeb	91	14	Shedding	shed	VBG
cord-301107-0njnjqeb	91	15	Light	Light	NNP
cord-301107-0njnjqeb	91	16	on	on	IN
cord-301107-0njnjqeb	91	17	the	the	DT
cord-301107-0njnjqeb	91	18	Effect	Effect	NNP
cord-301107-0njnjqeb	91	19	of	of	IN
cord-301107-0njnjqeb	91	20	Natural	Natural	NNP
cord-301107-0njnjqeb	91	21	Anti	Anti	NNP
cord-301107-0njnjqeb	91	22	-	-	NNP
cord-301107-0njnjqeb	91	23	Herpesvirus	Herpesvirus	NNP
cord-301107-0njnjqeb	91	24	Alkaloids	Alkaloids	NNPS
cord-301107-0njnjqeb	91	25	on	on	IN
cord-301107-0njnjqeb	91	26	SARS	SARS	NNP
cord-301107-0njnjqeb	91	27	-	-	HYPH
cord-301107-0njnjqeb	91	28	CoV-2	CoV-2	NNP
cord-301107-0njnjqeb	91	29	:	:	:
cord-301107-0njnjqeb	91	30	A	A	NNP
cord-301107-0njnjqeb	91	31	Treatment	Treatment	NNP
cord-301107-0njnjqeb	91	32	Option	option	NN
cord-301107-0njnjqeb	91	33	for	for	IN
cord-301107-0njnjqeb	91	34	COVID-19	COVID-19	NNP
cord-301107-0njnjqeb	91	35	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	91	36	disease	disease	NN
cord-301107-0njnjqeb	91	37	:	:	:
cord-301107-0njnjqeb	91	38	part	part	NN
cord-301107-0njnjqeb	91	39	I.	I.	NNP
cord-301107-0njnjqeb	91	40	Diagnosis	Diagnosis	NNP
cord-301107-0njnjqeb	91	41	,	,	,
cord-301107-0njnjqeb	91	42	clinical	clinical	JJ
cord-301107-0njnjqeb	91	43	features	feature	NNS
cord-301107-0njnjqeb	91	44	,	,	,
cord-301107-0njnjqeb	91	45	and	and	CC
cord-301107-0njnjqeb	91	46	pathogenesis	pathogenesis	NN
cord-301107-0njnjqeb	91	47	Reactivation	reactivation	NN
cord-301107-0njnjqeb	91	48	of	of	IN
cord-301107-0njnjqeb	91	49	human	human	JJ
cord-301107-0njnjqeb	91	50	herpesviruses	herpesviruses	NNP
cord-301107-0njnjqeb	91	51	6	6	CD
cord-301107-0njnjqeb	91	52	and	and	CC
cord-301107-0njnjqeb	91	53	7	7	CD
cord-301107-0njnjqeb	91	54	in	in	IN
cord-301107-0njnjqeb	91	55	Kawasaki	Kawasaki	NNP
cord-301107-0njnjqeb	91	56	disease	disease	NN